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This thesis explores the use of next generation sequencing as a tool to investigate the 
genomics of bacterial pathogens of plants and humans.  
Firstly, second-generation sequencing was applied to the evolution of distantly related 
bacterial species that have converged on common host plants (Xanthomonas bacteria on 
sugarcane and common-bean plants). This revealed evidence of recent horizontal gene 
transfer between X. phaseoli pv. phaseoli and X. citri pv. fuscans and between X. axonopodis 
pv. vasculorum and X. vasicola. distantly related sugarcane pathogens. Furthermore, we 
discovered that strains isolated from lablab bean (a close relative of common bean) form a 
previously unknown third distinct clade (and perhaps pathovar) and whole-genome 
comparisons suggested horizontal gene transfer played an important role in the evolution of 
host specificity in xanthomonad pathogens.  
Next, second-generation sequencing was used to rapidly gain insight into novel 
emerging bacterial pathogens, namely unusually virulent Asian strains of the human 
pathogen Campylobacter jejuni and a xanthomonad causing unusual symptoms on common 
bean in African country of Rwanda. A type six secretion system was shown to be associated 
with a more serious form of campylobacteriosis and a molecular marker for an intact type six 
secretion system was identified. This was shown to be more prevalent in strains isolated from 
Asia than strains isolated in the UK, a finding which has serious implications for chicken 
import. Further to this the genome sequence of a newly emerging Xanthomonas bean 
pathogen isolated from a recent outbreak in Rwanda is presented. Analysis of the Rwandan 
Xanthomonas genome shows it represents the first sequenced isolate in a novel species level 
clade, which was subsequently named as Xanthomonas cannabis and is genetically distinct 
from previously known bean pathogens. 
Lastly, the performance of the third-generation sequencing platform Oxford 
Nanopore MinION was assessed which will prove to be an exciting resource to perform 
bacterial genomic studies in the future. In summary, this work exemplifies the value of 
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This thesis is concerned with the bioinformatics analysis of data largely generated by 
collaborators on the various project discussed here in. The author planned and 
carried out the bioinformatics analysis detailed here and unless otherwise stated 
other results mentioned were generated by collaborators and are mentioned in this 
document in order to support the conclusions of the project. 
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The scientific field of molecular biology was revolutionised in the latter part of 
the last century with the advent of DNA sequencing. This revolutionary technology 
has brought about a rapid and still accelerating rate of discovery that shows no signs 
of slowing. In fact, in the field of modern molecular biology and ‘omics’ the limiting 
factor is no longer the generation of sequencing data or the constraints of wet bench 
laboratory work, but in data analysis and computational power. These technological 
advances have allowed the bloom of genomics research over the last few decades. 
 
Sequencing  
The development and refinement of DNA sequencing has opened up a wealth 
of possibilities. Researchers are now able to answer questions that were, until the 
advent of low cost next generation sequencing (NGS) technologies, at best difficult 
and more likely impossible. Recent studies have included data from thousands of 
bacterial genomes (e.g. 1,2) and the publishing of full genome sequences happens on 
a regular basis 3–6. In order to store and disseminate the huge amounts of data 
generated and published by the scientific community worldwide, massive online 
repositories have developed. These include the GenBank database hosted by the 
National Centre for Biotechnology Information (NCBI) 7, the European Nucleotide 
Archive hosted at the European Bioinformatics Institute (EBI) and many others. The 
development of specialist repositories for organism- or subject-specific genomic 
information have made available a huge amount of data which is at the fingertips 
(quite literally) of any researcher with internet access. 
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 The first DNA sequence was announced by Frederick Sanger in 1975. 
Sanger, who died in 2013, later received two Nobel prizes for his work on DNA and 
protein sequencing which had changed the face of bioscience and biomedical 
research forever. Sanger continued to contribute to the field publishing his final 
research paper in 1982 containing the first large genome sequence at 48,502 b.p. of 
genomic DNA: that of the now famous bacteriophage lambda 8. In 1986, the first 
automated DNA sequencing technology was pioneered by researchers at Caltech 9 
and released commercially by a group comprising of several factions including 
Applied Biosciences (ABI) and The European Molecular Biology Laboratory (EMBL).  
 The history of Sanger sequencing is littered with seminal discoveries. 
Beginning with the first phage sequence 8 there have since been many exciting 
discoveries such as the sequence of the 320000 bp chromosome III of 
Saccharomyces cerevisiae in 1992 10. The first completed bacterial genome 
sequence was that of Haemophilus influenzae, published in 1995 11 beginning a 
trend which is still gaining momentum. Soon completed genomes began to be 
published regularly; notable examples include the sequences for model organisms 
such as the bacterium Escherichia coli in 1997 12 and the model multi-cellular 
eukaryote Caenorhabditis elegans in 1998 13. This explosion in the volume of 
sequence data generated necessitated the creation of the modern fields of 
bioinformatics and computational biology. In the early stages of DNA sequencing 
sequences deposited in repositories such as NCBI were largely short partial gene 
sequences. This was until the early 1990s when whole genome sequence data 
began to be generated. The amount of genome sequence data held in public data 
bases has grown at an astonishing rate, with (as of June 2016) 71296 prokaryotic 
genomes, 3275 eukaryotic genomes and 5576 viral genomes available at various 
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stages of completion. As time and technology progresses the volume of sequence 
data increases (see Figure 1).  
Not only did the advent of DNA sequencing facilitate the sequencing of 
genomes of single organisms, but many novel techniques were made possible. The 
development of molecular microbial profiling made a significant, far reaching and 
long-term contribution to fields such as environmental ecology and clinical biology. 
This method was applied by Giovannoni et al. in their 1990 study using primers 
   
 
Figure 1: Graph of number of sequences held in the NCBI genbank repository.  
The lines represent sequences in GenBank (red) and whole genome sequences (blue). The y 
axis is a log scale. Data obtained from 124. 
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targeting the 16S rDNA gene, ubiquitously conserved among prokaryotes, to 
interrogate marine samples from the Sargasso Sea 14. They discovered the SAR11 
clade of bacteria (now known as Pelagibacterales) which have since been suggested 
to be the most numerous bacteria in nature 15.  
The Sanger method was refined and added-to for the following decades and 
this technology is still used today as a companion to more modern approaches. It 
offers a cost effective method of investigating specific questions targeted at 
particular regions of sequence. Often interesting or potentially controversial findings 
identified using less accurate NGS methods are confirmed using Sanger sequencing 
e.g.16. 
In 2001 possibly the most revolutionary advance in the field of molecular 
biology was announced, the first two sequences of the human genome 17,18. Actually, 
completed by two competing teams of researchers one led by Craig Ventner and the 
other by Eric Lander, this momentous achievement heralded a new age of genomics. 
DNA sequencing was again to take a significant leap forward in 2006 with the 
release of the GS20 by 454 life sciences 19. This was the beginning of a new wave of 
sequencing technologies known as NGS. 454 life sciences pioneered 
pyrosequencing a technology still used today (e.g. 20) although it has been largely 
superseded by more modern methods. Pyrosequencing facilitated the generation of 
previously undreamt of amounts of sequence data and opened the way for other 
NGS technologies. The characteristic benefits of this new methodology, particularly 
the high throughput massively parallel nature, democratized sequencing and allowed 
individual research groups access to resources previously only open to a few large 
sequencing centres worldwide 21. 454 sequenced large amounts of short (100 to 700 
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base pairs 22) lengths of DNA which could be processed bioinformatically in order to 
answer diverse biological questions. 
Since Roche’s ground-breaking method was released there have been 
several other competing technologies which have progressed the field of sequencing 
further. Arguably, the most successful NGS technology to date 23 is Illumina/Solexa – 
also released in 2006. The Illumina technology is again based around sequencing 
short lengths of DNA. Template DNA is prepared by fragmenting the input material 
using various methods such as restriction enzymes or sonication. These fragments 
are then size-selected to enrich for a specific size (typically around 600 – 800 bp). 
Adapters are then ligated to the fragmented strands of DNA. The sequencing 
actually takes place on a flowcell: the Illumina flowcell has millions of primers 
attached to its surface, which bind the corresponding adaptor on the input material. 
This allows the accurate positioning of each strand of DNA on the flowcell. In situ 
PCR is then carried out creating clusters of copies of each template strand. The 
sequencing is actually carried out by washing the flowcell with its clusters of template 
DNA with many rounds of fluorescently tagged nucleotides, taking a high-resolution 
image and using proprietary image analysis software to interpret the results at each 
nucleotide, generating a usable sequence. To generate paired end reads the 
molecules are inverted on the flowcell and the process is repeated, generating the 
pairs of reads with a ‘known’ gap 24 . The benefit Illumina displayed over its 
competitors was the volume of data generated and the cost per base pair of this 
sequence data 25. At its inception, the Illumina GAII was able to produce 1GB of 
sequence data with reads of 32 bp in length, already a massive leap from previous 
instruments. However, soon the length of the reads generated and the amount of 
sequence data generated from a single run grew and by 2014 the HI-SEQ 2000 was 
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routinely able to produce 5 billion reads of 150 pairs from a single flowcell (see table 
1 for detail of Illumina technologies). A further benefit afforded by Illumina 
sequencing was the generation of different types of reads. Paired end and mate pair 
sequencing involved the generation of sequence reads of normal Illumina length 
from two ends of the same molecular fragment of DNA with a known distance in 
between 26. Typically, for paired-end sequencing the fragment size is around 600 
base pairs and for mate pair reads the fragment size could be much larger. These 
more complex read types allowed much more information to be gained from the 
sequence data. The known fragment size and therefore the gap between the reads 
generated facilitated the placing of reads in a genomic context. This improved the 
accuracy and effectiveness of assembling sequence reads into longer contiguous 
sequences better representing the template from which they were generated 26. 
These improvements, along with advances in library preparation protocols and 
further improvements to the parallelisation and throughput of the system have made 
multiplexing many samples on one flowcell easy and cost effective, bringing the cost 
and availability of huge and varied sequencing projects into the realms of most 
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Table 1: table of the properties of Illumina sequencing technologies.  




There are problems inherent in Illumina sequencing technologies 27–30, which 
have been addressed to a greater or lesser extent since its introduction. There are 
the obvious issues with the use of short reads which Illumina technology shares with 
its competitors. Initially Illumina reads were very short, and consequentially, of 
limited utility for tasks such as de novo genome assembly, but still useful for other 
applications such as resequencing and RNA profiling. However, as read lengths 
increased, so did the uses that Illumina data was put to. By the time the HiSeq 2000 
was released, it was capable of generating 5 billion paired reads of 150 b.p. the 
Illumina age had firmly taken hold. Illumina sequencing incurs an error rate of 
approximately 0.1% 31, which although it sounds high, is counterbalanced by the 
depth of coverage generated. Each base position in the template DNA is sequenced 
many times allowing post sequencing analysis to highlight these systematic errors 
and lessen or eradicate their effects. There are other errors that can cause issues; 
library preparation often includes PCR amplification that has its own error rates and 
biases. However, as the technology, wet bench preparation techniques and data 
analysis matured, these problems were overcome. Illumina has become the world 
leader in sequencing technologies and regularly releases new sequencers such as 
the NovaSeq 6000 and the NextSeq which supersede the HiSeq. 
The Illumina sequencing technology is incredibly versatile and has many 
applications utilizing the particular characteristics of this short-read sequencer to the 
best effect32. Draft genome sequences are routinely generated, the short reads 
being assembled in silico to produce usable genomic sequence to inform studies on 
a wide range of diverse subjects. These subjects range from bacterial comparative 
genomics studies such as this one to producing the draft genome sequence of 
complex eukaryotic organisms  such as the western lowland gorilla (Gorilla gorilla 
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gorilla) 33. Illumina sequencing is routinely used for resequencing and alignment to 
reference genomes in order to identify small variations and polymorphisms between 
individuals or closely related isolates. This process can be used to elucidate 
evolutionary mechanisms and can identify genomic markers of phenotypic variation 
or uncover associations between genetic markers and human disease. It is even 
possible to detect epigenetic modifications in human DNA using Illumina sequencing 
and bisulphite treatment (e.g. 34). 
The development of sequencing methods certainly has not stopped with the first 
wave of NGS. Recently, a new wave of advances colloquially known as “third 
generation” sequencing have been released with the Pacific Biosciences Single 
Molecule Real Time technology (SMRT) probably the best known and is already 
installed in many sequencing centres 35. This novel process is able to sequence long 
molecules of DNA a number of times, generating long accurate consensus reads, 
which can be used to assemble genomic DNA de novo or scaffold contigs generated 
by other sequence technologies. Pacific Biosciences claim that it will be possible to 
detect epigenetic modifications during the sequencing reaction, pushing forward that 
field of study. A notable competitor, producing excitement in the field is the Oxford 
Nanopore Technologies MinION - heralding the advent of the portable, real-time 
sequencer 36 (Figure 2). The MinION uses nanopore technology to sequence long 
single molecules of DNA. The DNA molecules pass through nanopores in a micro 
sheet and the electrical potential across the pore can be measured. The MinION 
measures the signal not from each single base but from 5- or 6-mers as they move 
thorough the nanopore each one of these 5- or 6-mers resulting in a different 
reading. The analysis of these signals allowing the identification of each base in the 
sequence 36. This technology has the potential to generate very long reads of up to 
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100 kb and beyond 36,37. These new developments are still very much in their infancy 
and are dealing with similar teething problems as NGS experienced in its early days 
with high error rates, library preparation challenges and cost still issues to be 
addressed 38. However, their potential is enormous and with fourth generation 
sequencing already being discussed, the rate of advancement is only picking up 
pace 38. The release of more efficient and less error prone technologies from 
companies such as Pacific Biosciences (Sequel II) and Oxford Nanopore 
(PromethION) are already beginning to produce results 38. Due to the novel nature of 
these new approaches this project focuses mainly on data generated using NGS, 
namely the Illumina Hi-Seq with the addition of an assessment of the Oxford 
Nanopore Minion. Therefore from this point forward in the introduction discussion of 





Figure 2: The Oxford Nanopore MinION.  




 Obviously, the generation of such vast amounts of sequence data creates its 
own challenges. Computational capacity has risen dramatically and necessarily so, 
the cost of sequencing has dropped dramatically (Figure 3 A + B) Figure 3A shows 
the costs per megabase of sequence data and Figure 3B shows the costs per 
human sized genome. A steep drop in cost can be observed in 2008 when NGS 
technologies began to replace traditional Sanger technology in sequencing centres. 
A line representing Moore’s law is included for comparison. Technologies which 
keep up with Moore’s law are viewed as successful, and as can be seen, sequencing 
has vastly outpaced it  39. New computational approaches had to be developed to 
answer the questions posed by the amount and nature of the data generated. Fast 
efficient sequence alignment software such as BWA 40 and BOWTIE 41 were 
developed to align short reads generated from NGS to reference sequences. 
Genome assemblers such as VELVET 42 and SPAdes 43 use De Brujin graphs to 
efficiently produce reliable assemblies from short reads alone. The annotation of 
genomic sequence which was once a laborious time consuming process has now 
been automated with online services such as RAST 44 and the NCBI’s Prokaryotic 
Genome Annotation Pipeline 45 making the accurate annotation of prokaryotic 
sequence fast and simple. Even eukaryotic sequences can now be annotated in an 
automated way with some degree of confidence with tools such as MAKER 46 







Figure 3A: Graph showing the reduction in cost of sequencing per 
megabase of sequence when compared to Moores law. 
Figure 3B: Graph showing the reduction in cost of sequencing the 
human genome when compared to Moores law. 





As mentioned previously, the generation of such vast amounts of NGS data 
has necessitated the expansion of the field of bioinformatics. The impact of this fast 
evolving field has been immense, with almost every bioscience field now influenced 
by its discoveries and methodologies, from clinical genetics to ecology. Studies from 
disparate fields of biology are now using some facet of DNA sequencing technology 
to answer questions specifically related their fields. Marine ecologists are 
undertaking vast sequencing efforts to attempt to increase the understanding of 
marine microbiomes using metagenomic analysis 47,48. Clinical disease outbreaks 
are being studied in minute detail using the latest technologies to inform researchers 
and clinicians in the outbreak routes of these emerging diseases. Novel genetic traits 
can quickly and reliably be identified which make these novel strains more 
successful and therefore, worrying and the methods to control outbreaks can be 
quickly developed 49–51. 
 To facilitate these advances and discoveries there are some core methods 





Data analysis: Overcoming the bottleneck and introduction to methods 
used  
 
The amount of data generated by NGS platforms is huge and without a 
sensible standardised way of presenting and storing this data the analysis process 
would be all but impossible. Fortunately, early in the development of this new 
technology the Wellcome Trust Sanger Institute created the fastq file format52 (figure 
4). This was an important development, as previous formats did not store the 
necessary information in one place. The fastq format stores each read as four 
separate lines with the quality information of each base sequenced stored as a 
separate line to enable the quality assessment of the sequencing from information 
held in one file. 
Typically, data generated from the Illumina platform is in the form of short 
reads of between 32 (for older technologies) and 300 b.p. in length. As previously 
mentioned they can come in the form of paired end or mate pair reads. The 
technological limitations of NGS technologies result in a drop of in the quality 
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therefore the reliability of the sequence data as the read gets longer. Software such 
as FASTQC 53 can give excellent actionable metrics to assess the quality of NGS 
data and allow informed trimming and filtering by packages such as TRIMMOMATIC 
54 and FASTQ-MCF 55 which eradicate low quality reads and portions of reads to 
give the best hope of gaining accurate results from downstream analysis. 
  
Alignment of short sequencing reads to a reference 
 The alignment of short NGS reads to a reference genome is a process 
common to many applications of these data56. This process is used extensively to 
identify patterns of variation between individuals, isolates or sequences. However, 
there are problems inherent in both the data and the application. The reads are short 
sub-sequences of a much larger template and are likely to contain errors. Given the 
repetitive nature of certain genomic regions there are possibly several places which 
the short read can align57. The whole process presents a massive computational 
challenge as alignment must be performed for many thousands or millions of short 
reads. This is made even more challenging as one of the most useful applications of 
this process is to identify regions of difference between two closely related 
sequences, be that individual polymorphic bases, short inserted or deleted regions 
(indels) with respect to the reference and missing genes or whole regions. This 
means that the alignment process must take into account the possibility of these 
variations and report the best alignment comparison possible. 
 These issues have been dealt with using complex computational algorithms in 
such software as BOWTIE 58, BOWTIE2 59 and BWA 40 which use the Burrows 
Wheeler transform to create a permanent reusable index for the reference genome. 
The short reads are then aligned to this reference at a colossal rate, for BOWTIE this 
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can reach speeds of up to 25 million reads per CPU hour. For a comprehensive 
explanation of protocols see 41. 
  The amounts of data and results generated by this process present 
challenges for analysis, presentation and storage. There are several widely used 
packages that have various tools designed to standardise and facilitate the analysis 
of NGS data. The most widely used are SAMtools 60 and the Genome Analysis Tool 
Kit (GATK) produced by the Broad institute 61. These sequence analysis toolboxes 
allow the efficient analysis of large NGS datasets and have had a great impact on 
the field by attempting to standardise formats and protocols used throughout the field 
in an effort to unify global research techniques. 
 
De novo assembly of short sequencing reads 
 The assembly of short NGS reads into larger contiguous lengths of sequence 
representative of the template from which they were based upon has had may 
approaches 62,63. The most popular of which has been the use of De Bruijn graphs to 
reduce the computational burden of dealing with such massive amounts of short and 
error prone reads. Examples of software which utilise this method include VELVET 
64, SPAdes 43 and SOAPdenovo 65. This method essentially breaks the reads down 
into k-mers – substrings of sequence. A graph is then created with each portion of 
each k-mer as a distinct node and the k-mers as a directed edge in the graph. 
Algorithms are then used to pick the most efficient path through the graph and 
therefore the most likely sequence 66. 
The success of genome assembly from short reads depends a great deal on 
the pre-assembly quality control of the data generated by the sequencer. As 
mentioned previously, sequencing does have inherent error rates (for Illumina it is 
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approximately 1 error in 1000 bases sequenced 22 and these errors can obviously 
cause great problems when assembling into a representative contig. Therefore, 
eradicating as many of the unreliable portions of the sequence reads prior to 
sequencing improves the accuracy of the finished result. 
 The genome assembly process is more normally a pipeline consisting of pre 
assembly filtering and trimming, repeated iterations of assembly with various 
parameters including k-mer length, followed by post assembly verification. Post 
assembly verification is performed using the original short read data and aligning this 
back to the assembly generated, in an attempt to identify breakpoints where the 
assembly process has become confused. The assembly is then broken at these 
points and an attempt can be made to reassemble the contigs using paired read data 
to inform the process.  
There are issues inherent with the nature of the data produced by NGS and 
the templates being sequenced. Genomes tend to have repeated regions, mobile 
elements, pseudogenes and any number of other sequence anomalies that make 
assembly using short reads challenging. For example, if a motif repeat is longer than 
the reads generated then the assembly process is unable to ascertain the length of 
the region and the assembly will most likely break at this point. If there are several 
duplications within the template, the assembly may become confused leading to 
artefacts being included in the final assemblies or a large amount of (sometimes 
short) contigs. For example long repeated regions can be collapsed into a single 
element of the repeat in the final assembly, misrepresenting the true sequence. Any 




Assembly using short NGS data has developed into a field in its own right with 
the NCBI genomes database containing over 70,000 bacterial and over 3000 
eukaryotic genomes (as of 2016), not to mention viral, plasmid and organellar 
sequences. There has even been a number of assembly competitions to assess the 
performance of different assembly groups and software pipelines 67,68. 
 
Comparative genomics approaches 
Comparative genomics, as mentioned earlier, has been one of the fields of 
study made possible by the invention and proliferation of DNA sequencing and has 
gained in momentum vastly since the advent of NGS lowered the cost and increased 
the throughput and versatility of the process. DNA forms the blueprint of all life on 
earth. Genomic sequences code the information necessary for each organism to 
perform all of its biological processes. These genomic features are many and varied 
and come in the form of DNA sequence, genes, gene order, structural variation and 
RNA to name but a few and the list is ever growing as new elements are added as 
their functions are discovered. Even minute variation in these elements can have a 
profound effect on the phenotype of the organism concerned and is responsible for 
the biological diversity still being uncovered. The sequencing of many closely related 
individuals or isolates and comparing the sequence information generated allows 
insight into the genomic nature of phenotypic characteristics. A huge amount of 
research effort has been dedicated to this field of study, and the basic methodology 
has been applied to a vast array of disparate taxa from bacteria 69 to eukaryotes 70 
,humans 71 and even viruses 72. It is by examining the minute differences between 
closely related organisms and the similarities between evolutionarily diverse but 
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phenotypically convergent organisms that we have been able to begin to unpick the 
puzzle that genomics has unlocked. 
 It could be said that the first comparative genomics study was carried out with 
the publishing of the second genome sequence in the mid-1970s but it was not until 
the mid-1990s that the first comparisons between whole genomes of cellular 
organisms became a possibility. The Tatusov et al paper in 1996 compared the 
recently published genome sequence of H. influenzae with that of E. coli 73, marking 
the beginning of what we know today as comparative genomics. Several landmark 
studies followed using comparative genomics to uncover unprecedented amounts of 
genomic diversity within bacterial species. Campylobacter jejuni was found to have 
large numbers of homopolymeric repeats in genes responsible for surface structure 
biosynthesis or modification 74 and the Bacteroides fragilis genome was found to 
contain many inverted DNA repeats 75. There are other sequencing approaches that 
can be used and there are many questions that lend themselves to slightly different 
forms of genomic investigation such as microarray studies. Willenbrock et al 
designed a microarray useful to characterise the pan and core genome of E. coli 76 
with  Dickinson et al and Han et al 77,78 characterising structural variation in canine 
tumour cell DNA and the chicken genome respectively.  
 The study of prokaryote genomics benefitted from the application of 
comparative genomics approaches. Given the diversity of phenotypes displayed by 
prokaryotes and the relatively simplistic genomic organisation when compared to 
eukaryotes, it is not surprising that these fascinating organisms have been the focus 
of much scientific research. One of the earliest studies to utilise NGS for comparative 
genomics was Baker et al 2008 79. This study compared 140 isolates of Salmonella 
enteric serovar Typhi from Indonesia. The field has grown steadily however along 
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with the resources afforded by advancements in both sequencing technologies and 
computing power.  
 Comparative genomics studies have also revealed insight into bacterial 
evolution, showing the high incidence of horizontal gene transfer in species such as 
E. coli 80. Comparative genomic studies have also facilitated the identification, 
cataloguing and comparison of bacterial virulence and avirulence factors. There are 
many examples of this particularly relevant are studies focusing on type three 
secretion system (T3SS) effectors such as Bart et al 81 which compared 65 strains of 
Xanthomonas axonopodis pv. manihotis identifying the conserved and variable 
effector profile for this pathovar. 
 Large-scale sequencing projects are becoming more and more common and 
with the reduction in cost and improvements in technology and library preparation 
the number of genomes sequenced in each study is rising (Figure 5). This along with 
the improvements in sequencing technology, computing resources and analysis tools 








Bacteria are the most numerous biological organisms on the planet. They can 
be found in every environment imaginable and have evolved to not only survive but 
flourish in some of the most inhospitable environs known. Bacteria have been 
isolated from deep sea hydrothermal vents 82,83, hot springs 84, glacial ice sheets 
thousands of years old 85, arctic soil 86 and even outer space 87! The symbiotic nature 
of certain bacterial taxa is well known 88, there are examples of prokaryotic 
 
Figure 5: Graph showing the increase in numbers of genomes sequenced in a single project 
until 2014. 
 Data courtesy of 123. 
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symbionts existing within eukaryotes and even other bacteria 89. It has been recently 
revealed how important the fauna of the gut is to human health and the bacteria 
present in the digestive systems of ruminants has long been known to facilitate the 
digestion of cellulose 90. Further to this, the endosymbiotic theory has been 
suggested. It is now widely accepted that ancient symbioses between early 
eukaryotes and internal prokaryotes gave rise to certain eukaryotic organelles such 
as the plastid and, more anciently and perhaps contentiously, the mitochondrion and 
the basal flagellar body 91. This is supported by much evidence including the 
presence of discrete genomic material in both the plastid and the mitochondria which 
has much more in common with prokaryotic material than their host eukaryote, for 
example the unusual small subunit rDNA genes encoded by the plastid and 
mitochondrial genomes. However, it is research into the genomics of pathogenic 
bacteria which have garnered perhaps the most intense research effort as these 
bacterial species have the most direct and significant effect on the human 
population. There are many bacteria directly impacting human health such as the 
now famous Methicillin resistant Staphylococcus aureus or highly infectious 
pathogens such as Clostridium botulinum, Vibrio cholera, Mycobacterium 
tuberculosis and Salmonella enteriditis serovar Typhi which have caused untold 
human suffering and mortality. However, there are also bacterial pathogens with an 
indirect effect on human wellbeing for example plant pathogens. There are many 
examples of these bacterial pathogens affecting crops such as Xanthomonas 
species, Pseudomonas species and Ralstonia species. These pathogens have been 




 There are some elements of bacterial physiology that make them ideal 
candidates for genomic study. In comparison to eukaryotic organisms, even 
unicellular eukaryotes and protists, prokaryotes are far less complex. That being said 
they are still fantastically intricate biological machines that we are still far from fully 
appreciating. Important for this study are the genomic features which set bacteria 
apart. Bacteria have no nucleus; therefore, their genomic material is much easier to 
access. Bacteria have relatively small genomes, ranging from less than 240 kb in 
length (e.g. Candidatus tremblaya princeps 92) up to the modest (comparatively 
speaking) ~13 mb genome of Sorangium Cellulosum 93 . The bacterial genomic DNA 
is organised into chromosomes, normally singular but can be more for example 
Vibrio cholera is known to possess two 94 . These chromosomes are divided into 
non-intronic genes, with very little non-coding DNA.  
 As well as their genomic DNA, many bacterial species also possess extra 
chromosomal DNA in the form of plasmids 95. These can be circular or linear in 
nature and can range in size from tiny plasmids of less than 1kb in length such as 
the Candidatus tremblaya phenacola PAVE plasmid to several mb which are 
equitable in size to bacterial chromosomes such as the pSCL4 mega-plasmid found 
in Streptomyces clavuligerus 96. These plasmid sequences can code for many 
important functions; there are often genes held on plasmids which have an influence 
on important evolutionary processes such as niche adaptation and pathogenicity the 
importance of which will be covered later. Plasmids can also be exchanged between 
bacteria of different species, genera or even more distantly related taxa through 
conjugation. Plasmid conjugation is not the only method of accelerated evolutionary 
change; bacteria have also been shown to exchange genomic sequence. 
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Horizontal gene transfer (HGT) events have been shown to be numerous 
throughout the long history of bacterial evolution 80. HGT has been an extremely 
important driver of the evolutionary process both micro and macro, allowing the 
transfer of genes coding for certain traits between distantly related taxa, thus 
potentially sharing genomic information important to survive in certain environments 
or hosts. These methods are vital elements facilitating the spread of bacterial 
species to disparate environmental niches and lifestyles 97,98.  
 Bacterial taxonomy has always proved to be a difficult subject, due in no small 
part to their microscopic unicellular nature. Morphologically there are many specific 
structures which can be used to differentiate between taxa and metabolic and 
biochemical characteristics can also be used. However, due to the enormous variety 
of prokaryotes and their unicellular nature, identification, differentiation and grouping 
is an issue for traditional taxonomic strategies. In the age of almost universal access 
to affordable sequencing technologies however, the use of genomics for 
classification is far more successful. Sanger sequencing was, and to certain extent 
still is used for the purpose of attempting to assess the topology of the bacterial tree 
of life. There were numerous studies focusing on single gene or a small number of 
genes for use in molecular phylogenetics 99. Many bacterial genes were sampled to 
use as phylogenetic markers 99, the success of each being dependent on the 
question being asked. Highly conserved housekeeping genes are excellent 
candidate for single gene phylogenies trying to assess the relationships amongst 
quite disparate taxa as they are slowly evolving therefore evolutionarily distant taxa 
can be compared. The most widely used example is the 16S small subunit rRNA 100 
gene which is ubiquitous throughout the bacterial kingdom. However, being 
ubiquitous and slowly evolving are exactly the characteristics that make it less 
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suitable for more high resolution questions focusing on more closely related species. 
It has been suggested that the 16S gene is of little use as a taxonomic marker for 
higher than genus level perhaps species level studies 100. For these finer resolution 
questions, it is often more appropriate to use genes that are perhaps less wide 
spread and faster evolving. For example Gyrase B(GyrB) 101 the gene which ecodes 
the B subunit of the gyrase enzyme vital for DNA replication is a well-accepted 
taxonomic marker for sub-genera level taxonomy in Xanthomonas species. A further 
option for molecular bacterial taxonomy and classification is multi locus sequence 
analysis (MLSA) in which analysis is performed on concatenated markers from a 
number of genes, or indeed their full lengths 99.   
 
Bacterial secretion systems 
One group of bacterial cellular mechanisms that has been highlighted as 
important for both niche adaptation and pathogenicity is the secretion systems. 
These miniature biological machines are utilised by Gram-negative bacteria to 
translocate a wide variety of substrates from the intra-cellular space to either the 
periplasm, the extracellular space or to the interior of another cell. 
 To date there have been seven secretion systems (Figure 6) identified in 
Gram-negative bacteria, numbered 1-7. Five of these systems are known to 
translocate substrates from the cell interior to the cell exterior bridging both the inner 
and outer cell membranes: type 1, type 2, type 3 type 4 and type 6 secretion 
systems. Although for the purposes of this project the focus will be on the type 3 and 




Type three secretion system 
The bacterial T3SS is analogous to a molecular needle which is assembled by 
the bacterial cell. These nano-syringes are used by a wide variety of bacteria, mainly 
proteobacteria 102 with a variety of lifestyles including pathogens and symbionts. The 
T3SS machinery is coded for by more than twenty genes 103 including hrp which 
forms the subunits that build the needle apparatus. The structure of the T3SS was 
first identified in Salmonella typhimurium 104 has been shown to be closely related to 
that of the bacterial flagellum and it has been suggested that the T3SS has either 
evolved directly from this system 105 or that the two systems share a common 
ancestor 106 . These double membrane embedded nanomachines deliver effector 
proteins into the cytoplasm of target cells. These effector proteins have been shown 
to have several functions: targeting and subverting specific cellular processes within 
the target cells in order to facilitate the survival, colonisation and reproduction of the 
pathogen. These proteins, known as effectors, have been shown to have essential 
functions in the bacterial cells pathogenic repertoire. The effector complement of 107 
each bacterial strain can differ widely depending on host or lifestyle in which it needs 
to survive and the adaptations host organisms have evolved to combat infestation.  
 The zigzag model of plant pathogen interaction suggested by Jones and 
Dangl 108 posits a two stage immune response to bacterial invasion in plants. The 
first stage is based on the recognition of pathogen associated molecular patterns 
(PAMPS) by pattern recognition receptors (PRRs) in the plant cell. These PRRs 
recognise PAMPS triggering an immune response known as PAMP Triggered 
Immunity (PTI). PAMPs are slowly evolving molecular signatures of bacterial 
pathogens such as flagellin 109 and lipopolysacharides 110 which are an integral 
element of the outer membrane of gram negative bacteria. These PAMPs are 
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important to the bacterial cell, and not easily lost or changed so make excellent 
targets for host cell PRRs. As a reaction to this immune response bacteria have 
evolved secretion systems such as the T3SS which secrete effector proteins which 
interfere with and subvert the PTI in the host. However, the host organism uses 
polymorphic ND-LRR proteins to  
recognise these effectors.  These ND-LRR proteins then trigger the second more 
severe effector triggered immune response (ETI) thus develops an arms race 
between host and pathogen, with effectors variously being both virulence and 
 
Figure 6: Schematic of the different types of bacterial secretion systems. Courtesy of 107.  
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avirulence factors depending on the time in the host pathogen interaction cycle. 
Pathogens gain novel effector proteins through, for example horizontal gene transfer, 
which give them the edge over the host, which in turn evolves novel ND-LRR 
proteins to recognise these threats and evoke a response. Modifications to the 
zigzag model have been suggested 111 such as the inclusion of damage associated 
molecular patterns (DAMPS) which is the plant recognising bacterial damage and 
triggering immunity based on this 112.  
   
 
Type 6 secretion system 
 The Type 6 Secretion System (T6SS) was initially discovered in Vibrio 
cholerae in 2006 113 and is not as well characterised as the T3SS. Since its 
 
Figure 7; schematic of the zigzag model of plant-pathogen interaction. Courtesy of 108.  
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discovery, bioinformatics studies have identified the T6SS in 25% of gram negative 
bacterial taxa, including Escherichia species 114, Pseudomonas species 115 and 
Campylobacter species 116. Initially the T6SS was suggested to have a wide range of 
cellular functions including virulence 117 and host immunomodulation 118. Recent 
studies have also suggested further inter-bacterial functions for this secretion system 
such as bactericidal activity 119. The T6SS has been shown to be present in a wide 
range of pathogenic bacteria and there are known to be several copies in some 
species. The T6SS is known to be able to translocate effector proteins into both 
prokaryotes and eukaryotes 120. Two important signature proteins of the T6SS 
machinery are Hcp (haemolysin co-regulated protein) VgrG (valine-glycine repeat G) 
which have been suggested as both structural elements and translocated proteins 
115. 
 The T6SS genes are usually located on pathogenicity islands, for example 
the Vibrio pathogenicity island 1 island in Vibrio cholera. These genetic islands are 
now known to possess a variable number of genes, however the core components 
present in most known, functional T6SS are IcmF, IcmH, ClpV, Hcp and VgrG.  
 
Thesis aims and objectives 
This thesis describes the exploitation of recent technological developments in 
genome sequencing to investigate the genomics and evolution of pathogenicity in 
bacteria.  
In section 1 we aim to use next generation sequencing to identify and 
characterise novel genomic features of bacterial pathogens which influence host 
specificity and virulence exemplars being the T3SS and its effector complement. We 
characterise and compared these genomic features identifying effector profiles and 
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characterise the role of these in virulence. This will help address several related 
questions regarding the biology and the mechanisms of evolution of bacterial 
pathogenesis. The analysis we present here will identify novel signatures of 
increased virulence, phenotypic convergence and adaptation to new ecological 
niches in bacteria. This work has wide ranging potential to inform surveillance of 
these pathogens and the development of targeted resistance in crop management.  
Whilst multi-genome sequencing is commonplace in studies of human 
pathogens, at the outset of this project (in 2010), phytopathology lagged a little 
behind; yet the potential benefits were apparent. We focussed on a group of 
bacterial phytopathogens with huge impact for food security and economics from the 
Xanthomonas species. We aimed to use next generation sequencing to survey the 
genomic components of Xanthomonas pathogens of sugar cane and bean species to 
identify signatures of recent evolution of pathogenicity and adaptation to new hosts. 
We aimed to classify strains using molecular taxonomy and to use comparative 
genomics to identify genomic features facilitating phenotypic convergence and the 
colonisation of a host by distantly related pathogens 
  In section two we focus on the use of next generation sequencing and 
genomics to contribute to the understanding of emerging pathogens. Bacterial 
pathogens pose a huge threat to both human health and food security. 
Understanding the genomics of newly emerging threats can help track the spread of 
emerging bacterial threats and inform response; next generation sequencing 
provides an ideal tool to assist this analysis.  
We aimed to analyse two emerging bacterial threats. The first is a virulent 
form of Campylobacter infection found in the Far East. We use next generation 
sequencing and comparative genomics to identify genomic features characteristic of 
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this worrying infection. The study aims to contribute to knowledge of this potential 
threat to human health and to identify molecular markers to track possible outbreaks.  
The second example of the use of NGS to investigate a newly emerging 
bacterial threat is a recently identified Xanthomonas bean pathogen from a disease 
outbreak in Rwanda. We aimed to generate NGS data from this emerging pathogen, 
assemble the genome and use these data to classify this novel strain. We then 
survey and characterize genomic elements, contributing to the knowledge of this 
potentially serious emerging pathogen of beans.  
Finally, in section three of this thesis we present an early evaluation of the 
ONT MinION, one of the flagship examples of third generation sequencing 
technology. This technology has the potential to revolutionise the study of the 
genomics of bacterial pathogens. We will present a comprehensive assessment of 
the utility of this novel technology for bacterial sequencing and metagenomics. In 
order to explore several characteristics including data quality and read length and 
assess the implications of any limitations of this exciting technology three strains with 
varying genome size and G + C content were used. The ONT MinION has since 
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Bacterial species of the genus Xanthomonas are gram negative, rod shaped 
gamma proteobacteria. The xanthomonads are typically pathogens of plants 
and the genus contains a multitude of species groups and sub-species or 
pathovars. Each pathovar has evolved to have a narrow host range, often 
limited to just one or a very small number of host plants. Xanthomonas 
axonopodis pv. vasculorum (Xav) is one of several species of Xanthomonas 
which have evolved to infect sugarcane (Saccharum officinarum) including 
Xanthomonas vasicola pv. vasculorum (Xvv) and Xanthomonas sachchari. In 
this economically important crop plant, Xav has been shown to cause the 
destructive infection “gumming disease” which is one of the oldest recorded 
diseases of sugar cane in the world 1. Gumming disease has been described as 
a two stage infection. It begins with a foliar phase continuing on to a systemic 
phase later in the disease cycle. Among the early symptoms are yellowish, 
longitudinal stripes on the margins of the leaves which later develop into red or 
straw coloured stripes and the leaves can develop a bacterial sheen of exuded 
pathogen. The systemic infection follows with the chlorosis of younger leaves 
caused by the infection of the vascular bundles. The internal tissues of the stalk 
then develop pockets of gum-like bacterial exudate from which the disease 
gained its common name. 
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  Xav has afflicted global sugar cane agriculture for many years, causing 
massive damage to crops and economic loss. Xav displays similarities in both  
 
host range and phenotypic properties to Xvv and consequently there has been 
misidentification and taxonomic confusion when attempting to identify bacterial 
infections of sugar cane. Xav has historically been misidentified as 
Xanthomonas campestris pv. vasculorum and Xvv at various times. However, 
using molecular sequence analysis methods such as 2–4 it has been possible to 
differentiate Xanthomonas species to a greater degree. The species previously 
known as Xanthomonas campestris pv. vasculorum has been shown to divide 
into two phylogenetically distinct pathovars grouping in separate species level 
clades within the Xanthomonas genus, Xanthomonas vasicola and 
Xanthomonas axonopodis. These sequence-based taxonomic distinctions can 
be further verified using SDS-PAGE and fatty acid profiling 1,3,4. According to 
the classification scheme detailed in their 2000 paper, Dookun et al showed that 
Xav has a fatty acid type D which includes isolates of race 2 and 3. This 
classification grouped Xav with other pathovars collected from Reunion Island 
and Mauritius over a wide time period (1960 - 1992) from Sugar cane, 




Roystonea regia (Cuban royal palm) and Zea mays (maize) 1. This group 
phylogenetically branched along with type B (race 1) with in the X. axonopodis 
clade  
The pathovar now identified as Xav NCPPB 900 was first collected from 
Ravine Creuse Reunion island (Figure 6) in 1960 following an epidemic in the 
region. It was isolated from sugar cane by A. C. Hayward and deposited as 
B386. This pathovar was at the time known to cause serious problems to the 
sugar cane industry in the region 1. Although successful breeding strategies and 
other methods helped to control the disease there have been resurgences in 
the intervening time and has been suggested to be an emerging problem for 
sugar cane agriculture as recently as 2012 when it was identified in South 
America. Understanding the genomics of this pathogen would be of vital 
importance both from a food and economic security standpoint and for the wider 
scientific interest.  
 The isolate identified as Xav NCPPB900 was sequenced using next 
generation sequencing technology and assembled into a draft genome 
sequence. The hope was to investigate these data to identify novel genomic 
components of this pathogen which have facilitated adaptation to this host. 
Further, by comparison to other Xanthomonas species known to infect the same 
host, to identify incidents of horizontal gene transfer which may have been 
responsible for this phenotypic convergence. The aim of this work was also to 
investigate the recent evolutionary history of this bacterial pathogen. This would 
provide a resource to enable genomic comparison with other xanthomonads; 
particularly pathovars of X. axonopodis and other more distantly related species 
such as X. vasicola and X. sachari which have evolved independently to 
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 This study focuses on the investigation of two pathovars of Xanthomonas 
which are known to be pathogenic on bean species. These pathovars cause 
common bacterial blight (CBB)1, a devastating seed borne infection which 
presents a serious challenge to bean production in many African countries.  
Xanthomonas axonopodis pv. phaseoli (Xap) and Xanthomonas fuscans subsp. 
fuscans (Xff) both infect the common bean (phaseolus vulgaris) as their main 
host. However, these pathovars have also been known to infect the closely 
related species’ lima bean (Phaseolus lunatus) and lablab bean (Lablab 
purpureus) among other legumes2.  
 One of the major phenotypic characteristics which separates these 
strains is the production of brown pigment when cultured on tyrosine-containing 
media. Fuscous strains which produce the pigment are classified as Xff and 
those that do not produce the pigment (non-fuscous) are classified as Xap3.  
 There is some taxonomic confusion surrounding these strains, as non-
fuscous strains are classified within the Xanthomonas axonopodis species. 
However, the non-fuscous Xff have also been suggested to belong to a 
subclade of the same species or a distinct species in their own right4. 
There is also debate as to whether the strains isolated from the various 
bean hosts represent cases of single bacterial populations moving between 
hosts, or whether they form distinct genetic lineages or taxa. An interesting 
question as the identification of genomic variability and conservation between 
strains is an important part of the fight against bacterial pathogens. Identifying 
genetic markers and avirulence factors such as T3SS effectors can be used to 
inform the deployment of genetic resistance within the host plants in order to 
combat the spread of the disease caused by these pathogens5.   
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As discussed previously, genetic exchange between bacterial lineages is 
commonplace and given the convergence of hosts for these pathogen classes, 
it is interesting to identify incidences of genetic exchange and horizontal 
transfer between distinct bacterial lineages sharing the same host.  
 The aim of this study was firstly to improve existing genomic resources of 
Xanthomonas bean pathogens, sequencing, assembling, annotating and 
analysing the 26 chosen strains. This information can then be used to 
investigate the recent evolutionary history of these phylogenetically diverse 
bean pathogens. To identify shared genomic features possibly responsible for 
adaptation to this evolutionary niche and possible virulence factors such as 
T3SS effectors. These features, which have likely been exchanged by 
horizontal gene transfer between these pathovars likely have facilitated 
pathogenicity on legumes. Further, to determine a core effector complement to 
inform the future deployment of genetic resistance genes in bean agriculture. 
Finally, to investigate intra-pathovar genetic variation within these strains 
attempting to identify sequence variations which can be exploited as molecular 
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genome analysis used in this project. 
70 
 
 The author also contributed significantly to the pre-project research, 
concept design and planning for the project along with the writing, editing and 






























































































































































































































































































































































































































































































































































































































































































































Figure S2 Effect of depth of coverage on the contiguity of genome assembly. To assess the 
effect of depth of read coverage on assembly contiguity, we subsampled reads from the datasets 
for strains NCPPB 2064 and NCPPB 1058 to give a range of depths from 1 to 100 x. Depth of 
coverage was calculated by dividing the total number of nucleotides in the input sequence reads by 
4,700 (i.e. assuming that the genome size is 4.7 Mb). Each subsample of reads was assembled 
with SPAdes using the same protocol as for the assemblies described in the main text. The N50 
contig length was calculated for each assembly using Quast (Gurevich et al., 2013). 
 
Red circles (o): Genome sequence assemblies of Xff NCPPB 1058. 
 
 
































Figure S3 Whole-genome alignments of X. fuscans subsp. fuscans. The genome assemblies of each 














































































































































































































































































































































































































































Figure S6 A 60-kbp genomic deletion found in Sudanese lablab-associated isolates 
NCPPB 2064, NCPPB 556 and NCPPB 557 but not in Zimbabwean isolate NCPPB 
1713. The MiSeq sequence reads were aligned against the reference genome sequence 
of X. axonopodis pv. citri 306 (da Silva et al., 2002) using BWA-MEM (Li, 2013, 2014). The 
depth of coverage plots are visualised using IGV (Thorvaldsdóttir et al., 2013). 
 
 
Figure S7 A 8-kbp genomic deletion found in Xap NCPPB 3035 but not in other 
sequenced Xap GL1 isolates. The MiSeq sequence reads were aligned against the 
reference genome sequence of X. axonopodis pv. citri 306 (da Silva et al., 2002) using 
BWA-MEM (Li, 2013, 2014). The depth of coverage plots are visualised using IGV 




















































































































































































































































Figure S9 Conservation of Xff plasmid pla in the Xff and Xap isolates sequenced in 
the present study. The MiSeq sequence reads were aligned against the reference 
genome sequence of Xff 4834-R (Darrasse et al., 2013) using BWA-MEM (Li, 2013, 2014). 





















Figure S10 Conservation of Xff plasmid plb in the Xff and Xap isolates sequenced in 
the present study. The MiSeq sequence reads were aligned against the reference 
genome sequence of Xff 4834-R (Darrasse et al., 2013) using BWA-MEM (Li, 2013, 2014). 














































































Figure S10 (cont) Conservation of Xff plasmid plc in the Xff and Xap isolates 
sequenced in the present study. The MiSeq sequence reads were aligned against the 
reference genome sequence of Xff 4834-R (Darrasse et al., 2013) using BWA-MEM (Li, 


















Figure S11. Distribution of plasmids found in Xff CFBP4884. 
The distribution of each plasmid identified from Xff CFBP4884 across the three clades 
included in this study. The black boxes indicate presence of the plasmid, while white boxes 
indicate no evidence of the plasmid found in the assemblies. The grey boxes indicate partial 
sequence homology. The supplementary tree shows the topology of the fuscans clade in 










































































































































NCPPB2064 GCA_000786995.2 139 139 5,250,852 5,250,852 139 327,351 5,250,852 64.55 123,606 52,900 15 33 0 
NCPPB557 GCA_000808655.2 143 143 5,226,308 5,226,308 143 326,992 5,226,308 64.55 116,632 47,769 16 33 0 
NCPPB1128 71 71 4,950,425 4,950,425 71 475,671 4,950,425 68.89 107,247 74,331 14 27 0 
NCPPB1713 GCA_000807875.2 144 144 5,291,882 5,291,882 144 356,409 5,291,882 64.61 96,285 52,695 19 38 0 
NCPPB1159 GCA_000266285.1 128 128 4,797,980 4,797,980 128 257,906 4,797,980 65.18 96,063 46,574 17 36 0 
NCPPB1654 GCA_000775185.2 134 134 5,032,953 5,032,953 134 367,357 5,032,953 64.76 81,530 40,461 16 38 0 
NCPPB1680 GCA_000808695.2 158 158 5,117,812 5,117,812 158 224,929 5,117,812 64.9 77,618 47,328 24 45 0 
NCPPB1420 GCA_000785935.2 165 165 5,174,926 5,174,926 165 224,974 5,174,926 64.86 76,066 42,067 23 46 0 
NCPPB1056 GCA_000786945.2 134 134 5,150,070 5,150,070 134 233,487 5,150,070 64.77 75,549 44,652 20 42 0 
NCPPB381 GCA_000788075.2 136 136 4,955,361 4,955,361 136 231,088 4,955,361 64.89 74,010 38,888 21 43 0 
NCPPB1433 GCA_000775215.2 154 154 5,044,382 5,044,382 154 285,554 5,044,382 64.76 73,844 39,479 20 43 0 
NCPPB1158 GCA_000775205.2 152 152 5,109,687 5,109,687 152 231,811 5,109,687 64.77 73,833 40,466 22 45 0 
NCPPB3660 GCA_000786925.2  183 183 5,153,912 5,153,912 183 322,254 5,153,912 64.67 73,151 34,867 23 47 0 
NCPPB670 GCA_000764875.2 152 152 5,233,004 5,233,004 152 201,426 5,233,004 64.68 71,533 38,197 22 48 0 
NCPPB1058 GCA_000786935.2 168 168 5,180,142 5,180,142 168 324,288 5,180,142 64.7 71,334 35,921 25 49 0 
NCPPB2665 GCA_000775195.2 154 154 5,092,836 5,092,836 154 319,856 5,092,836 64.72 71,115 34,305 19 45 0 
NCPPB1495 GCA_000786915.2 158 158 5,197,608 5,197,608 158 194,645 5,197,608 64.64 70,760 36,664 24 50 0 
X621 GCA_000817715.2 165 165 5,017,028 5,017,028 165 177,805 5,017,028 64.8 70,719 36,776 26 50 0 
NCPPB1646 GCA_000785925.2 162 162 5,088,301 5,088,301 162 192,582 5,088,301 64.92 69,783 45,187 24 47 0 
NCPPB1811 GCA_000808675.2 170 170 5,202,962 5,202,962 170 225,593 5,202,962 64.71 68,458 36,539 26 51 0 
NCPPB301 GCA_000785945.2 153 153 5,047,533 5,047,533 153 192,590 5,047,533 64.95 67,789 45,183 25 48 0 
XCP123 GCA_000827975.2 169 169 5,153,892 5,153,892 169 220,101 5,153,892 64.84 66,622 44,427 25 49 0 
NCPPB1138 GCA_000808735.2 183 183 5,297,689 5,297,689 183 155,087 5,297,689 64.78 66,168 35,704 26 53 0 
NCPPB220 GCA_000808715.2 191 191 5,364,294 5,364,294 191 151,739 5,364,294 64.61 61,941 40,326 30 56 0 
X631 GCA_000827985.2 189 189 5,152,698 5,152,698 189 321,888 5,152,698 64.7 61,459 31,722 26 55 0 
NCPPB3035 GCA_000774035.2 190 190 5,225,427 5,225,427 190 151,633 5,225,427 64.74 59,899 34,433 28 56 0 
NCPPB556 GCA_000818835.2 288 288 5,191,650 5,191,650 288 166,874 5,191,650 64.58 41,494 18,726 38 88 0 
NCPPB1402 GCA_000774025.2 240 240 5,342,561 5,342,561 240 113,545 5,342,561 64.68 39,404 20,951 43 89 0 
Table S1 A. Information on assembly statistics for genomes used in this study. 
Information on assembly statistics for genomes used in this study –  statistics generated using 
QUAST.  
All statistics are based on contigs of size >= 500 bp, unless otherwise noted (e.g., "# contigs (>= 0 
bp)" and "Total length (>= 0 bp)" include all contigs). 
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IBSBF1411 130 130 4,856,132 4,856,132 130 314,799 4,856,132 65.17 111,064 48,882 15 32 0 
IBSBF2346 122 122 4,874,593 4,874,593 122 257,932 4,874,593 65.17 104,783 49,501 18 36 0 
CFBP1851 123 123 4,798,436 4,798,436 123 281,156 4,798,436 65.18 96,104 47,325 17 34 0 
NCPPB1159 128 128 4,797,980 4,797,980 128 257,906 4,797,980 65.18 96,063 46,574 17 36 0 
IBSBF2672 131 130 4,856,510 4,855,603 131 257,571 4,856,510 65.16 95,444 45,918 18 37 0 
IBSBF356 130 130 4,847,079 4,847,079 130 257,951 4,847,079 65.15 95,113 53,403 18 35 0 
IBSBF2345 128 125 4,819,772 4,816,940 128 286,963 4,819,772 65.23 94,514 49,498 19 36 0 
IBSBF320 121 121 4,803,726 4,803,726 121 257,673 4,803,726 65.19 94,274 49,412 17 36 0 
UA226 129 129 4,951,862 4,951,862 129 290,136 4,951,862 65 88,566 49,656 18 38 0 
IBSBF2820 150 150 4,930,429 4,930,429 150 257,651 4,930,429 65.11 88,415 42,506 19 40 0 
IBSBF278 138 138 5,020,210 5,020,210 138 239,334 5,020,210 64.89 88,339 44,175 20 41 0 
IBSBF436 149 149 4,903,327 4,903,327 149 257,580 4,903,327 65.15 83,955 44,597 19 39 0 
IBSBF2670 139 139 4,902,902 4,902,902 139 280,128 4,902,902 65.13 83,729 44,599 17 36 0 
UA324 146 146 4,916,013 4,916,013 146 161,357 4,916,013 65.09 77,947 42,353 22 44 0 
IBSBF725 141 141 4,886,517 4,886,517 141 257,945 4,886,517 65.15 77,096 46,873 19 40 0 
IBSBF2667 138 138 4,913,060 4,913,060 138 226,291 4,913,060 65.13 76,506 47,304 21 41 0 
Xam669 137 137 4,820,297 4,820,297 137 201,435 4,820,297 65.21 75,427 42,095 21 43 0 
UG27 131 131 4,903,342 4,903,342 131 268,832 4,903,342 65.06 74,810 44,155 19 39 0.02 
UG24 145 144 4,909,909 4,908,917 145 233,940 4,909,909 65.04 74,286 43,883 20 41 0.02 
IBSBF285 147 146 4,972,047 4,971,114 147 186,156 4,972,047 65.01 73,562 44,189 21 43 0.02 
IBSBF2816 145 144 4,902,619 4,901,640 145 256,960 4,902,619 65.12 73,453 44,328 19 39 0 
IBSBF726 140 137 4,832,905 4,829,984 140 257,968 4,832,905 65.18 72,346 42,156 21 42 0 
UG21 148 148 5,010,468 5,010,468 148 237,252 5,010,468 65.06 71,375 39,255 23 47 0 
ORSTX27 133 133 4,931,909 4,931,909 133 237,243 4,931,909 65.07 71,296 46,296 21 42 0 
UA536 142 142 4,866,301 4,866,301 142 183,757 4,866,301 65.13 71,281 41,126 23 45 0 
UA303 130 130 4,872,968 4,872,968 130 196,821 4,872,968 65.13 71,242 47,435 23 44 0 
IBSBF2821 161 161 4,906,958 4,906,958 161 257,592 4,906,958 65.13 71,007 39,076 21 44 0 
UG23 133 133 4,924,062 4,924,062 133 237,150 4,924,062 65.01 70,618 47,595 22 43 0 
AT6B 163 163 4,946,093 4,946,093 163 237,170 4,946,093 65.01 69,689 34,822 22 47 0 
UA306 144 144 5,065,231 5,065,231 144 235,368 5,065,231 65.01 69,670 43,868 23 45 0.02 
ORST17 177 173 5,128,104 5,124,410 177 235,384 5,128,104 64.95 69,510 43,949 23 45 0 
UA686 143 143 4,898,003 4,898,003 143 196,787 4,898,003 65.11 69,477 45,639 22 43 0 
UG51 140 140 4,871,289 4,871,289 140 234,400 4,871,289 65.13 69,454 42,988 22 44 0 
UA323 151 151 4,872,007 4,872,007 151 173,776 4,872,007 65.13 69,452 41,593 23 45 0 
IBSBF289 155 155 4,847,529 4,847,529 155 226,288 4,847,529 65.14 69,253 35,540 23 46 0 
CIO151 175 175 4,911,246 4,911,246 175 150,154 4,911,246 65.06 69,224 32,613 24 48 0 
UG43 145 145 4,924,182 4,924,182 145 237,167 4,924,182 65.02 66,987 40,722 23 46 0 







IBSBF2818 139 139 4,851,686 4,851,686 139 235,402 4,851,686 65.15 66,984 43,073 22 44 0 
UA556 139 139 4,842,655 4,842,655 139 237,273 4,842,655 65.14 66,984 43,073 22 44 0 
IBSBF2539 138 137 4,952,612 4,951,657 138 196,970 4,952,612 65.07 66,819 43,320 24 48 0 
AFNC1360 149 149 4,921,075 4,921,075 149 235,381 4,921,075 65.07 65,052 42,988 25 48 0 
Xam672 165 165 5,016,075 5,016,075 165 239,253 5,016,075 64.89 63,368 32,768 25 52 0 
UA560 154 154 4,897,922 4,897,922 154 176,262 4,897,922 65.1 61,397 39,165 27 52 0 
Xam1134 158 158 4,894,844 4,894,844 158 237,227 4,894,844 65.09 58,567 37,574 28 53 0 
Xam668 195 195 4,954,860 4,954,860 195 276,859 4,954,860 64.92 46,240 27,846 29 63 0 
Xam678 256 256 4,894,142 4,894,142 256 104,760 4,894,142 65.1 38,200 17,862 47 93 0 
IBSBF2666 311 311 4,842,277 4,842,277 311 123,056 4,842,277 65.1 28,335 15,839 49 105 0 
IBSBF2673 305 305 4,830,620 4,830,620 305 120,981 4,830,620 65.12 27,765 16,026 53 109 0 
UG45 323 323 4,986,397 4,986,397 323 83,811 4,986,397 64.89 25,647 14,923 59 123 0 
Thaiassembly.fna 
broken 324 322 4,874,623 4,872,860 324 84,544 4,874,623 65.16 25,423 14,825 62 124 0 
IBSBF2665 434 434 4,836,797 4,836,797 434 111,173 4,836,797 65.14 17,985 10,227 83 172 0 
IBSBF2822 464 463 4,831,349 4,830,360 464 57,666 4,831,349 65.13 17,213 9,515 93 188 0 
IBSBF2819 557 557 4,852,810 4,852,810 557 59,730 4,852,810 65.12 13,719 7,675 104 224 0 
IBSBF2538 573 573 4,833,429 4,833,429 573 50,456 4,833,429 65.1 12,527 7,291 122 249 0 
IBSBF1182 648 646 4,773,692 4,771,727 648 46,493 4,773,692 65.04 11,601 6,560 128 261 0 
UG28 676 672 4,722,734 4,719,002 676 54,751 4,722,734 65.14 10,796 6,238 131 276 0 
IBSBF614 706 706 4,730,788 4,730,788 706 51,491 4,730,788 65.03 10,598 5,680 136 291 0 
IBSBF1994 677 674 4,774,518 4,771,587 677 45,564 4,774,518 65.08 10,370 6,007 137 287 0 
NG1 785 784 4,737,721 4,736,722 785 38,252 4,737,721 64.9 9,229 5,016 160 335 0 
ORST4 767 766 4,650,210 4,649,231 767 36,169 4,650,210 65.03 9,012 4,950 161 336 0 
IBSBF280 850 848 4,842,752 4,840,771 850 41,005 4,842,752 64.81 8,666 4,696 171 358 0 
IBSBF321 888 883 4,593,056 4,588,103 888 35,503 4,593,056 64.9 7,483 4,318 183 389 0 
Table S1 B. information on assembly statistics for the genomes published by hajri et al 2012  
Comparison of assembly statistics for the genomes published by BART et al 2012 - statistics 
generated using QUAST. 
All statistics are based on contigs of size >= 500 bp, unless otherwise noted (e.g., "# contigs (>= 0 





KGK64681 fimbrial protein  
KGT57443 hypothetical protein  
KGU47595.1 hypothetical protein  
KGU48127.1 hypothetical protein  
KGU49471.1 hypothetical protein  
KGU50252.1 fimbrial protein  
KGU50381.1 NADPH:quinone oxidoreductase  
KGU50382.1 AraC family transcriptional regulator  
KGU50383.1 N-ethylmaleimide reductase  
KGU50384.1 TetR family transcriptional regulator  
KGU50385.1 short-chain dehydrogenase  
KGU50807.1 glyoxalase  
KGU50814.1 hypothetical protein  
KGU50868.1 hypothetical protein  
KGU50875.1 methyltransferase  
KGU50876.2 hypothetical protein  
KGU51538.1 membrane protein  
KGU51543.1 hypothetical protein  
KGU51683.1 modification methylase  
KGU51684.1 hypothetical protein  
KGU51685.1 hypothetical protein  
KGU51686.1 hypothetical protein  
KGU51744.1 hypothetical protein  
KGU52010.1 alpha/beta hydrolase  
KGU52011.1 LysR family transcriptional regulator  
KGU52012.1 FMN-dependent NADH-azoreductase  
KGU52013.1 hypothetical protein  
KGU52019.1 hypothetical protein  
KGU52023.1 hypothetical protein  
KGU52101.1 hypothetical protein  
KGU52102.1 hypothetical protein  
KGU52107.1 hypothetical protein  
KGU52614.1 hypothetical protein 
KGU52669.1 hypothetical protein  
KGU52846.1 beta-lactamase  
KGU52847.1 transcriptional regulator  
KGU53094.1 hypothetical protein  
KGU53261.1 methyltransferase  
KGU53514.1 hypothetical protein  
KGU53764.1 pilus assembly protein PilV  
KGU53765.1 pilus assembly protein  
KGU53766.1 pilus assembly protein PilE  
KGU53769.1 pre-pilin like leader sequence  
KGU53770.1 pilus assembly protein  
KGU54237.1 integrase  
KGU55371.1 galactarate dehydrogenase  
KGU55372.2 glucarate dehydratase  
KGU55373.1 glucarate transporter  
KGU55374.1 2 5-dioxovalerate dehydrogenase  
KGU55375.1 5-dehydro-4-deoxyglucarate dehydratase  
KGU55376.1 LysR family transcriptional regulator  
KGU55422.1 porin  
KGU55563.1 hypothetical protein  
KGU56157.1 TonB-dependent receptor  
KGU56374.1 membrane protein  
KGU56715.1 hypothetical protein  
KGU56733.1 hypothetical protein  
KGU56734.1 amine oxidase  
KGU56735.1 polysaccharide biosynthesis protein  
KGU56736.1 ribonuclease III  
KGU56737.1 hypothetical protein  
KGU56829.1 hypothetical protein  
KGU56830.1 hypothetical protein  
KKW48692.1 hypothetical protein  
















































































































































KKW48794.1 hypothetical protein  
KKW48949.1 hypothetical protein  
PRJNA263153:NB99 22880 hypothetical protein  
 
Accession Description 
KHS31773 hypothetical protein  
KHS32523 hypothetical protein  
KHS32525 hypothetical protein  
KHS32582 baseplate assembly protein  
KHS32717 transposase  
KHS32718 hypothetical protein  
KHS32719 hypothetical protein  
KHS32720 hypothetical protein  
KHS32721 hypothetical protein  
KHS32722 hypothetical protein  
KHS32723 hypothetical protein  
KHS33554 hypothetical protein  
KHS33556 integrase  
KHS33557 hypothetical protein  
KHS33797 hypothetical protein  
KHS33831 tail fiber assembly protein  
KHS33832 hypothetical protein  
KHS33862 hypothetical protein  
KHS33863 hypothetical protein  
KHS33864 hypothetical protein  
KHS33930 hypothetical protein  
KHS34155 hypothetical protein  
KHS34162 hypothetical protein  
KHS34252 hypothetical protein  
KHS34301 hypothetical protein  
KHS34370 hypothetical protein  
KHS34371 integrase  
KHS34433 hypothetical protein  
KHS34435 BadM/Rrf2 family transcriptional regulator  
KHS34436 thioredoxin reductase  
KHS34456 ATPase  
KHS34457 chemotaxis protein CheY  
KHS34561 hypothetical protein  
KHS34585 type III secretion system protein InvA  
KHS34586 hypothetical protein  
KHS34587 hypothetical protein  
KHS34588 hypothetical protein  
KHS34589 hypothetical protein  
KHS34590 hypothetical protein  
KHS34591 type III secretion system protein  
KHS34592 hypothetical protein  
KHS34593 hypothetical protein  
KHS34594 hypothetical protein  
KHS34595 hypothetical protein  
Table S3. Genes found in Xap GL1 but absent from Xff and lablab-associated Xap. 
Each of these genes was covered over at least 95% of its length by sequence reads from each of the 
sequenced Xap GL1 genomes but covered by no more than 30% of its length by aligned reads from 
any of the Xff or lablab-associated Xap genomes. 
Breadth of coverage was based on alignments of the genomic sequences reads against the 






KHS34596 hypothetical protein  
KHS34597 hypothetical protein  
KHS34598 hypothetical protein  
KHS34599 hypothetical protein  
KHS34600 hypothetical protein  
KHS34601 hypothetical protein  
KHS34602 hypothetical protein  
KHS34627 protein-S-isoprenylcysteine methyltransferase  
KHS34635 LuxR family transcriptional regulator  
KHS34637 hypothetical protein  
KHS34671 hypothetical protein  
KHS34690 nitrite reductase  
KHS34691 MFS transporter  
KHS34692 nitrate ABC transporter substrate-binding 
KHS34836 hypothetical protein  
KHS34920 oxidoreductase  
KHS34921 LysR family transcriptional regulator  
KHS34930 glutamyl-tRNA(Gln) amidotransferase subunit A  
KHS34931 membrane protein  
KHS34937 transcriptional regulator  
KHS34966 hypothetical protein  
KHS35235 hypothetical protein  
KHS35333 hypothetical protein  
KHS35341 hypothetical protein  
KHS35507 hypothetical protein  
KHS35625 AraC family transcriptional regulator  
KHS35626 peptidase S41  
KHS35637 TonB-dependent receptor  
KHS35638 hypothetical protein  
KHS35639 hypothetical protein  
KHS35733 hypothetical protein  
KHS35747 hypothetical protein  
KHS35763 hypothetical protein  
KHS35765 hypothetical protein  
KHS35777 hypothetical protein  
KHS35962 hypothetical protein  
KHS36059 membrane protein  
KHS36099 hypothetical protein  
KHS36103 hypothetical protein  
KHS36305 peptide-binding protein  
KHS36321 hypothetical protein  
KHS36395 hypothetical protein  
KHS36488 hypothetical protein  
KHS36558 hypothetical protein  
KHS36587 transcriptional regulator  
KHS36599 hypothetical protein  
KHS36611 hypothetical protein  
KHS36756 hypothetical protein  
KHS36820 hypothetical protein  
KHS36905 hypothetical protein  
KHS36918 hypothetical protein  
KHS36926 cation transporter  
KHS36933 transporter  
KHS36941 RNA methyltransferase  
KHS36962 coproporphyrinogen III oxidase  
KHS36963 metalloenzyme domain-containing protein  
KHS36964 hypothetical protein  
KHS36965 ATPase AAA  
KHS36967 hypothetical protein  
KHS36974 hypothetical protein  
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KHS37170 hypothetical protein  
KHS37202 RNA polymerase sigma70  
KHS37316 glucan biosynthesis protein  
KHS37329 membrane protein  
KHS37355 hypothetical protein  
KHS37356 sulfotransferase  
KHS37357 ABC transporter ATP-binding protein  
KHS37558 hypothetical protein  
KHS37688 hypothetical protein  
KHS37689 hypothetical protein  
KHS37690 hypothetical protein  
KHS37779 hypothetical protein  
KHS37780 hypothetical protein  
KHS37803 ArsR family transcriptional regulator  
KHS37933 hypothetical protein  
KHS37990 hypothetical protein  
KHS38607 hypothetical protein  
KHS38608 hypothetical protein  
KHS38895 hypothetical protein  
KHS38947 fimbrial protein  
KHS38949 pilus assembly protein  
KHS39041 3-deoxy-manno-octulosonate cytidylyltransferase  
KHS39043 methyltransferase  
KHS39101 hypothetical protein  
KHS39108 addiction module protein  
KHS39222 ketosteroid isomerase  
KHS39223 LysR family transcriptional regulator  
KHS39227 chloride channel protein  
KHS39521 hypothetical protein  
KHS39674 hypothetical protein  
KHS39807 hypothetical protein  
KHS39921 hypothetical protein  
KHS40058 hypothetical protein  
KHS40082 histidine kinase  
KHS40083 hypothetical protein  
KHS40090 chitinase  
KHS40367 histidine kinase  
KHS40369 Tfp pilus assembly protein PilW  
KHS40886 hypothetical protein  
KHS40930 hypothetical protein  
KHS40957 hypothetical protein  
KHS41130 hypothetical protein  
KHS41166 hypothetical protein  
KHS41214 hypothetical protein  
KHS41218 transcriptional regulator  
KHS41299 hypothetical protein  
KHS41374 long-chain acyl-CoA synthetase  
KHS41375 long-chain fatty acid--CoA ligase  
KHS41376 short-chain dehydrogenase  
KHS41377 tetratricopeptide repeat protein  
KHS41378 transcriptional regulator  
KHS41390 histidine kinase  
KHS41417 aspartyl beta-hydroxylase  
KHS41418 cytochrome c biogenesis factor  
KHS41419 hypothetical protein  
KHS41420 sulfotransferase  
KHS41421 TonB-dependent receptor  
PRJNA270010:RN19 23245  chemotaxis protein  
PRJNA270010:RN19 23465  hypothetical protein  
PRJNA270010:RN19 23605  hypothetical protein  
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PRJNA270010:RN19 23805  hypothetical protein  
PRJNA270010:RN19 23905  pilus assembly protein  
PRJNA270010:RN19 24020  hypothetical protein  
PRJNA270010:RN19 24165  hypothetical protein  
PRJNA270010:RN19 24235  hypothetical protein  
PRJNA270010:RN19 24245  hypothetical protein  





KHF46216 hypothetical protein  
KHF46253 hypothetical protein  
KHF46840 hypothetical protein  
KHF46860 histidine kinase  
KHF49249 hypothetical protein  
KHS05251 hypothetical protein  
KHS05293 hypothetical protein  
KHS05314 hypothetical protein  
KHS05315 Type III restriction enzyme  res subunit  
KHS05316 DNA methylase  
KHS05318 hypothetical protein  
KHS05350 hypothetical protein  
KHS05374 hypothetical protein  
KHS05398 hypothetical protein  
KHS05399 hypothetical protein  
KHS05428 hypothetical protein  
KHS05432 oxidoreductase  
KHS05433 hypothetical protein  
KHS05434 hypothetical protein  
KHS05484 oxidoreductase  
KHS05485 epimerase  
KHS05489 pilus assembly protein PilW  
KHS05559 peptidase M61  
KHS05757 XRE family transcriptional regulator  
KHS05871 GCN5 family acetyltransferase  
KHS05996 hypothetical protein  
KHS05997 radical SAM protein  
KHS05998 hypothetical protein  
KHS06001 integrase  
KHS06149 hypothetical protein  
KHS06445 phosphopantetheinyl transferase  
KHS06764 enterocin  
KHS06882 aldehyde oxidase  
KHS06992 hypothetical protein  
KHS07180 hypothetical protein  
KHS07181 hypothetical protein  
KHS07201 phage tail protein  
KHS07203 arylsulfotransferase  
KHS07204 hypothetical protein  
Table S4. Genes found in lablab-associated Xap  but absent from Xff and Xap 
GL1. 
Each of these genes was covered over at least 95% of its length by sequence 
reads from each of the sequenced lablab-associated  Xap genomes but covered 
by no more than 30% of its length by aligned reads from any of the Xff or Xap 
GL1 genomes. 
Breadth of coverage was based on alignments of the genomic sequences reads 






KHS07206 SAM-dependent methlyltransferase  
KHS07207 asparagine synthase  
KHS07208 hypothetical protein  
KHS07209 hypothetical protein  
KHS07210 transposase  
KHS07211 methyltransferase  
KHS07212 membrane protein  
KHS07213 asparagine synthase  
KHS07214 hypothetical protein  
KHS07215 membrane protein  
KHS07216 glycosyl transferase family 1  
KHS07217 UDP-N-acetyl-D-mannosamine transferase  
KHS07218 ligase  
KHS07219 glycosyl transferase family 1  
KHS07220 UDP-phosphate glucose phosphotransferase  
KHS07221 glycosyl transferase family 1  
KHS07222 mannosyltransferase  
KHS07252 hypothetical protein  
KHS07253 hypothetical protein  
KHS07254 transporter  
KHS07255 sugar transporter  
KHS07256 methyltransferase type 12  
KHS07296 hypothetical protein  
KHS07297 hypothetical protein  
KHS07330 AraC family transcriptional regulator  
KHS07331 hypothetical protein  
KHS07332 START domain protein  
KHS07333 hypothetical protein  
KHS07334 short-chain dehydrogenase  
KHS07338 type III secretion system effector protein  
KHS07498 hypothetical protein  
KHS07499 hypothetical protein  
KHS07584 calcium-binding protein  
KHS07783 membrane protein  
KHS07836 hypothetical protein  
KHS07979 hypothetical protein  
KHS08090 hypothetical protein  
KHS08206 CopG family transcriptional regulator  
KHS08252 transcriptional regulator  
KHS08317 hypothetical protein  
KHS08379 hypothetical protein  
KHS08423 hypothetical protein  
KHS08765 hypothetical protein  
KHS08766 hypothetical protein  
KHS08767 glycosyl transferase family 9  
KHS08773 hypothetical protein  
KHS08981 ligand-gated channel  
KHS09024 UDP kinase  
KHS09025 flagellar biosynthesis protein FlhB  
KHS09026 flagellar biosynthesis protein FlhA  
KHS09027 flagellar hook-basal body protein  
KHS09028 flagellar hook-basal body protein  
KHS09029 flagellar basal body P-ring biosynthesis protein 
KHS09031 flagellar P-ring protein FlgI  
KHS09032 hypothetical protein  
KHS09033 hypothetical protein  
KHS09034 hypothetical protein  
KHS09035 ATP synthase  
KHS09036 hypothetical protein  
KHS09037 flagellar hook capping protein  
111 
 
KHS09038 flagellar hook-basal body protein  
KHS09039 hypothetical protein  
KHS09040 hypothetical protein  
KHS09041 flagellar biosynthesis protein flip  
KHS09042 RNA polymerase sigma-70 factor  
KHS09072 hypothetical protein  
KHS09073 hypothetical protein  
KHS09162 hypothetical protein  
KHS09164 hypothetical protein  
KHS09167 hypothetical protein  
KHS09270 hypothetical protein  
KHS31033 hypothetical protein  
PRJNA268142:QQ30 23585  transposase  
PRJNA268142:QQ30 23775  hypothetical protein  
PRJNA268142:QQ30 25245  hypothetical protein  
PRJNA268142:QQ30 26020  flagellar M-ring protein FliF  
PRJNA268142:QQ30 26715  hypothetical protein  
PRJNA269802:RM61 23105  hypothetical protein  
PRJNA269802:RM61 23120  glucose sorbosone dehydrogenase  
PRJNA269802:RM61 23125  peptidoglycan-binding protein  
PRJNA269802:RM61 23135  hypothetical protein  
PRJNA269802:RM61 23315  hypothetical protein  
PRJNA269802:RM61 23485  hypothetical protein  
PRJNA269802:RM61 23580  hypothetical protein  
PRJNA269802:RM61 24490  hypothetical protein  
PRJNA269802:RM61 24950  transposase  
PRJNA269802:RM61 25105  hypothetical protein  






KGU48816.1 hypothetical protein  
KGU50255.1 hypothetical protein  
KGU50386.1 hypothetical protein  
KGU50427.1 hypothetical protein  
KGU50466.1 LysR family transcriptional regulator  
KGU50467.1 short-chain dehydrogenase  
KGU50793.1 transducer protein car  
KGU50994.1 oxidoreductase  
KGU50995.1 AraC family transcriptional regulator  
KGU51344.1 integrase  
KGU51377.2 ADP-ribosylation/crystallin J1  
KGU51433.1 hypothetical protein  
KGU51457.1 hypothetical protein  
KGU51533.1 transposase  
KGU51650.1 hypothetical protein  
KGU51734.1 LysR family transcriptional regulator  
KGU51748.1 alpha/beta hydrolase  
KGU52009.1 endonuclease  
KGU52015.1 hypothetical protein  
KGU52017.1 hypothetical protein  
KGU52018.1 sulfate transporter  
KGU52020.1 methionine aminopeptidase  
KGU52021.1 hypothetical protein  
KGU52624.1 tail collar protein  
KGU52632.2 hemagglutinin  
KGU52827.1 adenylate cyclase  
KGU53452.1 hypothetical protein  
KGU53454.1 hypothetical protein  
KGU53466.1 dihydroorotate dehydrogenase  
KGU54122.1 membrane protein  
KGU54128.1 methyltransferase  
KGU54129.1 cytochrome P450  
KGU54131.1 hypothetical protein  
KGU54490.1 hypothetical protein  
KGU55549.1 hypothetical protein  
KGU55562.1 hypothetical protein  
KGU56526.1 hypothetical protein  
KGU56527.1 transcriptional regulator  
KGU56539.1 biopolymer transporter ExbD  
KGU56660.1 dipeptidyl-peptidase 7  
KHS34695 F420H2:quinone oxidoreductase  
KHS39585 plasmid stabilization protein  
KKW48473.1 hypothetical protein  
KKW48540.1 hypothetical protein  
KKW48549.1 hypothetical protein  
KKW48757.1 HpaF protein  
KKW48760.1 hypothetical protein  
KKW48810.1 resolvase  
PRJNA266873:PK63 22130  transposase  
 
 
Table S5. Genes found in Xap GL1 and Xff but absent from lablab-associated Xap.  
Each of these genes was covered over at least 95% of its length by sequence reads from each 
of the sequenced Xap GL1 and Xff genomes but covered by no more than 30% of its length by 
aligned reads from any of the lablab-associated Xap genomes. 
Breadth of coverage was based on alignments of the genomic sequences reads against the 







KHS05752 hypothetical protein 
KHS33391 hypothetical protein 
KHS33392 chemotaxis protein 
KHS33542 LysR family transcriptional regulator 
KHS34259 LysR family transcriptional regulator 
KHS34847 allophanate hydrolase 
KHS34848 urea carboxylase 
KHS35371 ATPase AAA 
KHS35992 hypothetical protein 
KHS37131 membrane protein 
KHS37132 membrane protein 
KHS37135 short-chain dehydrogenase 
KHS37136 FAD-linked oxidase 
KHS37137 membrane protein 
KHS37138 membrane protein 
KHS37723 RNA polymerase sigma70 
KHS37724 membrane protein 
KHS38567 hypothetical protein 
KHS38568 peptidase S8 
KHS39898 hypothetical protein 
KHS40273 hypothetical protein 
KHS40963 peptidase S9 
KHS41282 hypothetical protein 
KHS41283 hypothetical protein 
KHS41455 2OG-Fe(II) oxygenase 
PRJNA268142:QQ30 24300  aminopeptidase N 




KGK66335 hypothetical protein  
KGU50240.1 transposase  
KGU50511.1 membrane protein  
KGU50514.1 membrane protein  
KGU50785.1 short-chain dehydrogenase  
KGU50800.1 death-on-curing protein  
Table S6. Genes found in lablab-associated Xap and Xap GL1 but absent 
from Xff. 
Each of these genes was covered over at least 95% of its length by 
sequence reads from each of the sequenced lablab-associated Xap and Xap 
GL1 genomes but covered by no more than 30% of its length by aligned 
reads from any of the Xff genomes. 
Breadth of coverage was based on alignments of the genomic sequences 
reads against the reference pan-genome using BWA-MEM. 
Table S7. Genes found in lablab-associated Xff  and Xap GL1 but absent 
from Xap GL1. 
Each of these genes was covered over at least 95% of its length by sequence 
reads from each of the sequenced lablab-associated  and Xff genomes but 
covered by no more than 30% of its length by aligned reads from any of the 
Xap GL1 genomes. 
Breadth of coverage was based on alignments of the genomic sequences 
reads against the reference pan-genome using BWA-MEM. 
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KGU50805.1 hypothetical protein  
KGU50861.1 histidine kinase  
KGU50862.1 D-Ala-D-Ala carboxypeptidase  
KGU50874.1 transcriptional regulator  
KGU50901.1 HmsH protein  
KGU50902.1 hemin storage protein  
KGU50903.1 N-glycosyltransferase  
KGU50904.1 membrane protein  
KGU50924.1 ABC transporter ATP-binding protein  
KGU50925.1 peptide ABC transporter permease  
KGU50926.1 ABC transporter permease  
KGU50927.1 peptide ABC transporter substrate-binding 
KGU50928.2 acyl-CoA dehydrogenase  
KGU50929.1 ligand-gated channel  
KGU50930.1 FMN reductase  
KGU50931.1 alkanesulfonate monooxygenase  
KGU50932.1 ABC transporter substrate-binding protein  
KGU50933.1 ABC transporter permease  
KGU50934.1 sulfonate ABC transporter ATP-binding protein  
KGU50935.1 monooxygenase  
KGU50936.1 Fis family transcriptional regulator  
KGU50938.1 hypothetical protein  
KGU51006.1 TonB-dependent receptor  
KGU51239.1 UDP-glucose 6-dehydrogenase  
KGU51380.1 hypothetical protein  
KGU51386.1 hypothetical protein  
KGU51481.1 membrane protein  
KGU51655.1 glycerophosphodiester phosphodiesterase  
KGU51667.2 glycosyl transferase  
KGU51668.1 membrane protein  
KGU51715.1 hypothetical protein  
KGU51716.1 alpha/beta hydrolase  
KGU51724.1 Oar protein  
KGU51740.1 hypothetical protein  
KGU51858.1 hypothetical protein  
KGU51985.1 UDP-glucose 4-epimerase  
KGU51986.1 glycosyl transferase  
KGU51987.1 UDP-galactopyranose mutase  
KGU51988.1 beta-glucosidase  
KGU52001.1 ligand-gated channel  
KGU52007.1 hypothetical protein  
KGU52008.1 ABC-type phosphate transport system  periplasmic 
KGU52394.1 hypothetical protein  
KGU53190.1 hypothetical protein  
KGU53243.1 ketoacyl reductase  
KGU53262.1 UDP-3-O-(3-hydroxymyristoyl) glucosamine 
KGU53263.1 ribosomal subunit interface protein  
KGU53264.1 acetyltransferase  
KGU53265.1 3-oxoacyl-ACP reductase  
KGU53266.1 3-oxoacyl-ACP reductase  
KGU53267.1 3-oxoacyl-ACP synthase  
KGU53341.1 TonB-dependent receptor  
KGU53342.1 beta-galactosidase  
KGU53343.1 membrane protein  
KGU53368.1 aspartate aminotransferase  
KGU53369.1 phenazine biosynthesis protein PhzF  
KGU53370.1 permease  
KGU53546.1 hypothetical protein  
KGU53684.1 hypothetical protein  
KGU54168.1 type III secretion system effector protein  
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KGU54174.1 hypothetical protein  
KGU54281.2 hypothetical protein  
KGU54427.1 LysR family transcriptional regulator  
KGU54428.1 membrane protein  
KGU54447.1 TonB-dependent receptor  
KGU54455.1 flavodoxin  
KGU54482.1 hypothetical protein  
KGU54485.1 hypothetical protein  
KGU54486.1 hypothetical protein  
KGU54487.2 transcriptional regulator  
KGU54770.1 beta glucosidase  
KGU54771.1 ribokinase  
KGU54773.2 hypothetical protein  
KGU54774.1 TonB-dependent receptor  
KGU54958.1 esterase  
KGU54981.1 chemotaxis protein  
KGU54983.1 sulfate transporter  
KGU54984.1 peptidase M20  
KGU55170.1 NAD(P) transhydrogenase subunit beta  
KGU55175.1 transcriptional regulator  
KGU55215.1 membrane protein  
KGU55220.1 acetaldehyde dehydrogenase  
KGU55225.1 beta-lactamase  
KGU55237.1 aldehyde dehydrogenase  
KGU55325.1 TonB-dependent receptor  
KGU55326.1 nitrilotriacetate monooxygenase  
KGU55327.1 L-glyceraldehyde 3-phosphate reductase  
KGU55328.1 sulfonate ABC transporter substrate-binding 
KGU55817.1 IroE protein  
KGU55818.1 outer membrane receptor protein  
KGU55837.1 hypothetical protein  
KGU55974.1 hypothetical protein  
KGU56088.1 hypothetical protein  
KGU56145.1 alpha/beta hydrolase  
KHS05367 beta-lactamase  
KHS05368 transcriptional regulator  
KHS05493 fimbrial protein  
KHS05622 TetR family transcriptional regulator  
KHS05658 DeoR faimly transcriptional regulator  
KHS05953 alpha-N-acetylglucosaminidase  
KHS06150 recombinase  
KHS06212 hypothetical protein  
KHS06460 chemotaxis protein  
KHS06531 monooxygenase  
KHS06947 hypothetical protein  
KHS07522 hypothetical protein  
KHS07912 hypothetical protein  
KHS08114 hypothetical protein  
KHS08290 hypothetical protein  
KHS08753 hypothetical protein  
KHS08754 glyoxalase  
KHS08825 hypothetical protein  
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The genus Campylobacter (meaning “curved bacteria”) is a group of 
Gram-negative, microaerophilic, spiral shaped, motile epsilon proteobacteria 1. 
Campylobacter species are the principle bacterial cause of human foodborne 
enterocolitis worldwide 2 and as such cause untold suffering. Included within the 
Campylobacter genus there are seventeen species including well-known strains 
such as Campylobacter coli, Campylobacter fetus and Campylobacter pylori. 
Campylobacter species have been shown to colonise a number of diverse 
habitats, including livestock, poultry, humans 3. However, the species primarily 
associated with human infection are C. coli and C. jejuni 4. Within the genus and 
indeed within each species campylobacters display a variety of pathogenic 
effects and adaptation to a wide variety of ecological niches, all suggestive of a 
high level of genomic diversity within this genus.  
Campylobacter jejuni is one of the most well-known of the 
Campylobacter species and much study has been devoted to its biology. The 
first full genome sequence of C. jejuni NCTC 11168 was published in 2000 1. 
The genome of C. jejuni is one of the smaller bacterial genomes possessing 
one circular chromosome of 1,641,481 b.p. with a GC content of around 31%. 
The genome of C. jejuni NCTC 11168  was predicted to code for 1654 proteins 
and 54 RNAs. The C. jejuni genome is unusual in that it codes for very few 
insertion sequences, phage associated sequences or repeat sequences. 
Comparative studies have highlighted other unusual features associated with 
this pathogen for example hypervariable homopolymeric tracks and unusual 
lipooligosaccharide biosynthesis clusters 4. 
C. jejuni has been shown to be the major cause of Campylobacter-
associated diarrhoea in humans, causing more than 640,000 cases of diarrhoea 
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in 2011 in the United Kingdom alone 5 . This causes great distress for the 
sufferers and a heavy burden on health services. C. jejuni has been shown to 
be a zoonotic pathogen that forms part of the commensal flora in the 
gastrointestinal tract of birds such as chickens. This facilitates the infection 
process as a major route of C. jejuni transmission to humans is via the handling 
and consumption of undercooked or raw chicken 6. 
Despite the fact that C. jejuni has been shown to be a dominant global 
diarrhoeal pathogen with great impact on human health and health services, 
unlike many other common enteric pathogens, the mechanisms of 
pathogenesis of C. jejuni are not well understood. Additionally, confounding the 
complete understanding of the biology of this important human pathogen, there 
is a clear bias in our understanding of Campylobacter epidemiology. The weight 
of research effort into this subject has predominantly been concerned with C. 
jejuni infection in high-income countries, neglecting the low-income countries 
where C. jejuni infection is also rife. This is perhaps surprising as diarrhoeal 
disease is a leading cause of morbidity and mortality among children in Asia 
and C. jejuni has been shown to be a major cause of this disease burden 7,8. 
However, a potentially interesting association has arisen; there is a difference in 
disease phenotype in infected individuals in low- and middle-income countries 
versus high-income countries. Those individuals diagnosed with Campylobacter 
infections in low- and middle-income countries have been reported to suffer 
from non-inflammatory, watery diarrhoea. Conversely, Campylobacter infection 
diagnosed in Europe and North America are typically associated with 
inflammatory, bloody diarrhoea. This observation suggests that the mechanism 
of the disease is not identical but varies across the geographical locales 9. 
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These obsevations support a level of intra-species genetic variation between 
those isolates causing disease in the two geographical areas. 
As stated above, a novel class of protein translocation system has 
recently been identified in Gram-negative bacteria, the type 6 secretion system 
(T6SS). The role of this novel protein translocation system has been suggested 
to include pathogen-pathogen and host-pathogen interactions. The T6SS has 
been found to play a major role in virulence in a range of pathogens, including 
Vibrio cholera 10–13(reviewed in 14,15). Unlike other enteric pathogens, such as 
Salmonella spp. and E. coli, in C. jejuni classical virulence determinants such as 
type 3 secretion systems, insertion sequences or phage associated sequences 
have not been identified during genomic analysis (Parkhill et al., 2001). 
However, a functional T6SS was recently identified in C. jejuni (Lertpiriyapong 
et al., 2012). The newly discovered C. jejuni T6SS has several important roles 
in the virulence of this important enteric pathogen, including cell adhesion and 
invasion in colonic epithelial and macrophage cells and colonization of mice 
(Lertpiriyapong et al., 2012). However, the role the T6SS plays during the 
infection cycle in humans has not been investigated.  
The hemolysin co-regulated protein (hcp), is a highly conserved component of 
all characterized T6SS, including the functional C. jejuni T6SS (Das et al., 2000; 
Ishikawa et al., 2012; Parkhill et al., 2001; Parsons & Heffron, 2005; Pukatzk et 
al., 2006). It is believed that the hcp gene encodes either part of the 
translocation apparatus, or a secreted effector protein (Records, 2011). Prior to 
this project, the T6SS was identified in isolates from global studies of 
campylobacteriosis confirming the results published by Lertpyiapong et al (O. 
Champion - personal communication).  
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The aim of this study was to address the bias in C. jejuni genome 
sequencing data towards strains isolated in high-income regions, thus 
increasing both the volume and diversity of C. jejuni genomic resources. To 
survey the presence of the newly identified T6SS gene cluster over the full 
diversity of sequenced C. jejuni strains including those added by this study. 
Further to this the aim was to determine if there was a molecular marker that 
could be used to identify strains harbouring this marker and thus the T6SS gene 
cluster. This marker will then be used to survey strains from the UK and the far 
east to determine first whether there was an association between strains 
harbouring a T6SS with the more virulent form of C. jejuni infection and if these 
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Ref Hcp +ve 
305 Turkey Germany negative draft (Takamiya et al., 2011)  
       
327 Turkey Unknown negative draft (Takamiya et al., 2011)  
       
414 Bank Vole Unknown positive complete  yes 
1213 Cow USA negative draft   
1336 Bird Unknown positive complete (Hepworth et al., 2011)  
       
1577 Cow USA negative draft   
1798 Cow USA negative draft   
1854 Cow USA negative draft   
1893 Cow USA negative draft   
1928 Cow USA negative draft   
04197 Unknown Unknown negative draft   
04199 Unknown Unknown negative draft   
6399 Unknown Unknown negative draft   
51037 chicken USA positive draft  yes 
51494 chicken USA positive draft  yes 
53161 chicken USA positive draft   
60004 chicken USA negative draft   
81116 human Unknown negative complete (Pearson et al., 2007)  
86605 chicken USA negative draft   
87330 chicken USA negative draft   
87459 chicken USA positive draft   
110_21 Unknown USA negative draft   
129_258 Cow USA negative draft   
140_16 Cow USA negative draft   
1997_1 Human USA negative draft   
1997_10 Human USA positive draft  yes 
1997_11 Human USA negative draft   
1997_14 Human USA positive draft  yes 
1997_4 Human USA negative draft   
1997_7 Human USA negative draft   
2008_1025 Human France negative draft   
2008_831 Human France negative draft   
2008_872 Human France negative draft   
2008_894 Human France negative draft   
2008_979 Human France positive draft  yes 
2008_988 Human France negative draft   
260_94 Human S. Africa negative draft   
81_176 Human Unknown negative Complete (Russell, Blaser, Sarmiento, & Fox, 1989)  
84_25 Human Unknown negative Complete   
ATCC_33560 Cow Brussels positive draft  yes 
CG8421 Human Thailand negative draft (Poly et al., 2008)  
CG8486 Human Thailand negative draft (Poly et al., 2007)  
D2600 Human USA negative draft (Jerome et al., 2012)  
DFVF1099 chicken Unknown negative draft (Takamiya et al., 2011)  
H22082 Human 
New 
Zealand negative draft (Takamiya et al., 2011)  
HB93_13 Human China negative draft (Burrough, Sahin, Plummer, Zhang, & Yaeger, 2009)  
IA3902 Sheep USA negative Complete (Luo et al., 2012)  
ICDCCJ07001 Human China negative draft (Zhang et al., 2010)  
LMG_23210 chicken Belgium positive draft  Yes 
LMG_23211 chicken Belgium negative draft   
LMG_23216 chicken Belgium positive draft   
LMG_23218 chicken Belgium negative draft   




na positive draft  yes 
LMG_23264 Human Slovenia negative draft   
LMG_23269 chicken Belgium negative draft   
LMG_23357 water 
Netherland
s positive draft   
LMG_9081 human USA negative draft   






Strain name source country of origin T6SS Genome status Ref Strain source 
28766 Beach UK negative   This study 
KSCattle8 Cattle UK negative   This study 
11974 human UK negative   This study 
13305 human UK negative   This study 
11919 human UK negative   This study 
30280 human UK negative   This study 
11818 human UK negative   This study 
12241 human UK negative   This study 
99/188 human UK negative   This study 
99/197 human UK negative   This study 
99/97 human UK negative   This study 
0 1/ 43 human UK negative   This study 
99/189 human UK negative   This study 
99/216 human UK negative   This study 
94/229 human UK negative   This study 
99/212 human UK negative   This study 
BB1267 human UK negative   This study 
31467 human UK negative   This study 
31484 human UK negative   This study 
32799 human UK negative   This study 
31485 human UK negative   This study 
33084 human UK positive   This study 
93/372 human UK negative   This study 
32787 human UK negative   This study 
44119 human UK negative   This study 
47693 human UK negative   This study 
33106 human UK negative   This study 
34007 human UK negative   This study 
Hi40980306 human UK negative   This study 
90843 human UK negative   This study 
Hi40500471 human UK negative   This study 
Hi40620306 human UK negative   This study 
BB1267 human UK negative   This study 
Hi81266 human UK negative   This study 
Hi80586 human UK negative   This study 
Hi80547 human UK negative   This study 
Hi81006 human UK negative   This study 
KSSAPSM6 human UK negative   This study 
Hi81214 human UK negative   This study 
KSSHPSM4 human UK negative   This study 
99/118 Cow UK negative   This study 
99/201 Cow UK negative   This study 
99/202 Cow UK negative   This study 
C0599 3095 Cow UK negative   This study 
LMG_9872 Human Sweden negative draft   
LMG_9879 Human Canada negative draft   
M1 Human/poultry Unknown negative complete (Friis et al., 2010)  
NCTC11168 Human Unknown negative complete (Gundogdu et al., 2007)  
NW Human USA positive draft (Jerome et al., 2012)  
P110B chicken 
New 
Zealand negative draft (Gundogdu et al., 2007)  
P854 chicken UK positive draft  yes 
RM1221 Unknown Unknown positive complete (Fouts et al., 2005)  
S3 poultry Unknown negative complete (Cooper, Cooper, Zuccolo, Law, & Joens, 2011)  
doylei 269 97 Human Unknown negative complete   
xy259 Unknown Unknown negative draft   
55037 chicken USA negative draft   




C085 40995 Cow UK negative   This study 
1182 ENV Env UK negative   This study 
PS304 Pig UK negative   This study 
PS623 Pig UK positive   This study 
PS762 Pig UK negative   This study 
PS830 Pig UK negative   This study 
PS838 Pig UK negative   This study 
PS843 Pig UK positive   This study 
PS849 Pig UK positive   This study 
PS852 Pig UK positive   This study 
PS857 Pig UK positive   This study 
C120/2 Poultry UK negative   This study 
C132/1 Poultry UK negative   This study 
D2/T/80 Poultry UK negative   This study 
PS55491 Poultry UK positive   This study 
A83515A Poultry UK negative   This study 
A1CF12 Poultry UK negative   This study 
D502009A Poultry UK negative   This study 
C3/T2/8 Poultry UK negative   This study 
D2/27B Poultry UK negative   This study 
C3/T/25 Poultry UK negative   This study 
EX1286 Poultry UK negative   This study 
MB1 Poultry UK negative   This study 
MB2 Poultry UK negative   This study 
MB3 Poultry UK negative   This study 
MB4 Poultry UK negative   This study 
MB5 Poultry UK negative   This study 
MB6 Poultry UK negative   This study 
MB7 Poultry UK negative   This study 
MB8 Poultry UK negative   This study 
MB9 Poultry UK negative   This study 
MB12 Poultry UK negative   This study 
MB13 Poultry UK negative   This study 
MB14 Poultry UK negative   This study 
MB15 Poultry UK negative   This study 
MB16 Poultry UK negative   This study 
MB17 Poultry UK negative   This study 
MB18 Poultry UK negative   This study 
S2160509901 Sheep UK negative   This study 
S390209903 Sheep UK negative   This study 
S1200409904 Sheep UK negative   This study 
S8704099 Sheep UK negative   This study 
S3720509904 Sheep UK negative   This study 
S3790809901 Sheep UK negative   This study 
S43503099 Sheep UK negative   This study 
S4990109905 Sheep UK negative   This study 
S58503099 Sheep UK negative   This study 
Cj 54 Camel Pakistan negative   This study 
N2 human Pakistan negative   This study 
AKRH011 human Pakistan negative   This study 
702 human Pakistan negative   This study 
Y25 human Pakistan negative   This study 
2960HF human Pakistan negative   This study 
712 human Pakistan negative   This study 
K1 human Pakistan negative draft  This study 
K2 human Pakistan positive   This study 
K4 human Pakistan negative   This study 
K5 human Pakistan negative draft  This study 
       
K6 human Pakistan negative   This study 
K7 human Pakistan negative   This study 
K8 human Pakistan positive   This study 
80 Poultry Pakistan negative   This study 
255 Poultry Pakistan positive draft  This study 
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Cj245 waste water Pakistan negative   This study 
Cj 236 waste water Pakistan positive   This study 
Cj1 human Thailand positive draft  This study 
Cj2 human Thailand negative draft  This study 
Cj3 human Thailand negative draft  This study 
Cj5 human Thailand positive draft  This study 
20157 human Vietnam positive   This study 
30286 human Vietnam positive draft  This study 
30261 human Vietnam positive   This study 
10227 human Vietnam positive draft  This study 
20160 human Vietnam negative   This study 
30106 human Vietnam negative   This study 
20288 human Vietnam negative   This study 
30311 human Vietnam positive   This study 
20283 human Vietnam positive   This study 
10186 human Vietnam positive draft  This study 
20176 human Vietnam positive draft  This study 
20231 human Vietnam positive   This study 
20301 human Vietnam positive   This study 
30318 human Vietnam positive draft  This study 
20321 human Vietnam positive   This study 
20332 human Vietnam negative   This study 
30355 human Vietnam positive   This study 
20319 human Vietnam positive   This study 
20137 human Vietnam positive   This study 
30391 human Vietnam negative   This study 
30396 human Vietnam negative   This study 
10275 human Vietnam negative   This study 
20227 human Vietnam positive   This study 
30446 human Vietnam positive   This study 
20396 human Vietnam negative   This study 
10126 human Vietnam positive   This study 
20084 human Vietnam negative   This study 
30431 human Vietnam negative   This study 
30146 human Vietnam negative   This study 
10070 human Vietnam negative   This study 
10152 human Vietnam negative   This study 
20245 human Vietnam positive   This study 
71V103 Duck Vietnam negative   This study 
71V42 Duck Vietnam negative   This study 
71V489 Duck Vietnam negative   This study 
71V151 Duck Vietnam negative   This study 
71V135 Duck Vietnam negative   This study 
71V445 Duck Vietnam negative   This study 
71V484 Duck Vietnam negative   This study 
71V420 Duck Vietnam negative   This study 
71V409 Duck Vietnam negative   This study 
71V397 Duck Vietnam negative   This study 
71V49 Duck Vietnam negative   This study 
71V69 Duck Vietnam negative   This study 
72H57 Pig Vietnam negative   This study 
71V110 Duck Vietnam positive   This study 
71G139 Chicken Vietnam negative   This study 
71G142 Chicken Vietnam positive   This study 
71G356 Chicken Vietnam positive   This study 
71G570 Chicken Vietnam positive   This study 
71G784 Chicken Vietnam positive   This study 
71G998 Chicken Vietnam positive   This study 
71G1212 Chicken Vietnam positive   This study 
71G1426 Chicken Vietnam positive   This study 
71G1640 Chicken Vietnam positive   This study 
71G1854 Chicken Vietnam positive   This study 
71G2068 Chicken Vietnam positive   This study 
71G2282 Chicken Vietnam positive   This study 
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71G326 Chicken Vietnam negative   This study 
71G143 Chicken Vietnam positive   This study 
71G329 Chicken Vietnam negative   This study 
71G125 Chicken Vietnam positive   This study 
71G124 Chicken Vietnam negative   This study 
71G90 Chicken Vietnam positive   This study 
71G30 Chicken Vietnam positive   This study 
71G43 Chicken Vietnam negative   This study 





Table S3. List of primers 
Primers (for 
target genes) 




gltAF Cj GCCCAAAGCCCATCAAGCGGA 
142 bp 
60 This Study 
gltA F Cj GCGCTTTGGGGTCATGCACA 58 This Study 
Hcp F CAAGCGGTGCATCTACTGAA 
463 bp 
60 This Study 
Hcp R TAAGCTTTGCCCTCTCTCCA 60 This Study 
 


















Figure S1: Prevalence of T6SS genetic marker hcp in C. jejuni isolated from 
chickens in Vietnam and the UK. 
 
Figure S2. Prevalence of T6SS genetic marker hcp in C. jejuni isolated from 
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 This chapter introduces a newly described species of Xanthomonas, 
isolated from an outbreak of disease on common bean (Phaseolus vulgaris) 
crops in the Nyagatare region of the east African country of Rwanda (Figure 7). 
This novel Xanthomonas isolate shows unusual disease symptoms and whilst 
at present does not yet pose a significant agro-economic threat in the region, 
there is the potential for this pathogen to spread and impact crop production 
and consequently the wellbeing of the local population. Also, given the global 
nature of agro-economy is perfectly feasible that pathogens such as this can be 
spread widely though the plant and seed trade therefore it is important to 
develop fast comprehensive methods to assess these threats. Tentatively 
named Xanthomonas sp. Nyagatare, this new isolate is the first representative 
to be sequenced from a newly described species level clade. 
  
 This project presented an exciting opportunity to utilise next generation 




Figure 7: Map showing location of the Nyagatare region of Rwanda.  




emerging pathogen at an early stage of its outbreak timeline. It was hoped that 
this analysis would afford the opportunity to fully characterise the genome of a 
newly emerging pathogenic isolate of Xanthomonas, contributing to the 
understanding of the genomic variability of the genus and gaining an insight into 
the evolution and genomics of pathogenicity of Xanthomonas. Further to this, 
the characterisation and comparison of the Nyagatare species’ genomic 
features with those other Xanthomonas species would provide valuable 
information to track the spread and assess the impact of this emerging threat to 
east African bean agriculture.  
 The use of modern sequencing technologies and bioinformatics analysis 
to inform the investigation into new and emerging pathogens has been carried 
out to great success in other fields, notably the E. coli outbreak in European 
countries in 20111 and the Ebola outbreak in western Africa in 2015 2. These 
studies were large scale and had, quite understandably, a huge amount of 
international support, cloud sourced manpower and computational weight to aid 
the analysis effort. It was hoped that this project could show that similar analysis 
could be performed on smaller outbreaks with less resources available, but still 
provide in depth analysis which could be of both scientific and practical use to 
track the spread and successfully inform containment strategies for an 
emerging pathogen. 
It was hoped that this study detailed in this study would provide a 
valuable foundation for future work on this and other closely related 
Xanthomonas species. It would be very useful to carry out pathogenicity assays 
to confirm that this strain is indeed responsible for the disease outbreak on 
bean crops in Rwanda and fully assess its host range. This information along 
with the genome information would give a better idea of the threat posed by this 
144 
 
emerging pathogen. It would be interesting to profile the secreted effectors of 
this strain, both experimentally and bioinformatically in order to obtain a 
complete picture of the effector complement and to compare this with other 
strains including those of the recently published Jacobs et al. study. This would 
help to elucidate the recent evolutionary history of this group 
The aim of the work presented here was to use NGS technologies to 
characterise the genomics of a newly emerging bacterial pathogen of beans 
isolated during a recent outbreak in Rwanda. It was hoped to sequence, 
assemble and analyse this newly emerging pathogen. This would allow the 
classification and comparison of the Nyagatere strain with known xanthomonds, 
identifying virulence factors and genomic features which have facilitated the 
adaptation to this new ecological niche and identify potential molecular markers 




The author conducted all bioinformatic analysis for this project. This 
included using bespoke scripts and pipeline code to conduct the initial quality 
control of raw sequencing reads and the denovo assembly and analysis of this 
emerging strain. The author also conducted all analysis and bioinformatic 
comparisons of this strain with sequence databases. 
 The author also contributed significantly to the pre-project 
research, concept design and planning for the project along with the writing, 
editing and submission of manuscript and the production and editing of all 































Figure S1: Disease symptoms following inoculation of CAL96 in glass house 





Figure S2: The genome sequence of Xanthomonas sp. strain Nyagatare encodes a Hrp type-three 
secretion system. The Nyagatare sequence (GenBank: KN265463.1) was aligned against the 
chromsome  of X. campestris pv. campestris ATCC 33913 (GenBank: AE008922.1) using BLASTN and 







































































































3513693 73.73 Xanthomonas_arboricola.GCF_000585435  3518320 72.08 88.89 
3413084 71.13 Xanthomonas_axonopodis.GCF_000265805  3427722 70.22 88.71 
3412068 71.11 Xanthomonas_axonopodis.GCF_000266285  3426141 70.19 88.71 
3424828 71.06 Xanthomonas_axonopodis.GCF_000265925  3432830 70.33 88.72 
3421358 70.59 Xanthomonas_axonopodis.GCF_000265725  3435639 70.38 88.71 
3515768 70.57 Xanthomonas_fuscans_4834_R_uid222814.NC_022541  3463681 70.96 88.7 
3401045 70.56 Xanthomonas_axonopodis.GCF_000266685  3415339 69.97 88.73 
3422539 70.54 Xanthomonas_axonopodis.GCF_000266105  3424566 70.16 88.7 
3419195 70.53 Xanthomonas_axonopodis.GCF_000266225  3435147 70.37 88.72 
3415641 70.53 Xanthomonas_axonopodis.GCF_000266385  3425198 70.17 88.7 
3426030 70.4 Xanthomonas_axonopodis.GCF_000266365  3437267 70.42 88.71 
3381278 70.39 Xanthomonas_axonopodis.GCF_000265745  3388497 69.42 88.71 
3400692 70.37 Xanthomonas_axonopodis.GCF_000266265  3413510 69.93 88.73 
3427512 70.35 Xanthomonas_axonopodis.GCF_000266805  3435715 70.39 88.7 
3427534 70.34 Xanthomonas_axonopodis.GCF_000265565  3439453 70.46 88.7 
3428191 70.33 Xanthomonas_axonopodis.GCF_000265945  3435809 70.39 88.71 
3414094 70.3 Xanthomonas_axonopodis.GCF_000265885  3427253 70.21 88.73 
3422769 70.26 Xanthomonas_axonopodis.GCF_000266625  3435016 70.37 88.7 
3411634 70.25 Xanthomonas_axonopodis.GCF_000266005  3423575 70.14 88.73 
3440946 70.24 Xanthomonas_axonopodis.GCF_000265825  3454113 70.76 88.72 
3258331 70.07 Xanthomonas_axonopodis.GCF_000266305  3275729 67.11 88.89 
3415108 70.06 Xanthomonas_axonopodis.GCF_000266345  3427269 70.21 88.73 
3430754 70.04 Xanthomonas_axonopodis.GCF_000266425  3441086 70.5 88.71 
3430397 70.04 Xanthomonas_axonopodis.GCF_000266405  3438890 70.45 88.71 
3422737 69.93 Xanthomonas_axonopodis.GCF_000266645  3435683 70.38 88.71 
3380834 69.9 Xanthomonas_axonopodis.GCF_000265645  3394337 69.54 88.77 
3420773 69.88 Xanthomonas_axonopodis.GCF_000266585  3429706 70.26 88.7 
3373039 69.83 Xanthomonas_axonopodis.GCF_000266025  3387930 69.41 88.75 
3416913 69.82 Xanthomonas_axonopodis.GCF_000266725  3427408 70.22 88.71 
3422497 69.8 Xanthomonas_axonopodis.GCF_000266505  3432871 70.33 88.71 
3464221 69.74 Xanthomonas_alfalfae.GCF_000225915  3453257 70.74 88.75 
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3464221 69.74 Xanthomonas_axonopodis_citrumelo_F1_uid73179.NC_016010  3453257 70.74 88.75 
3425464 69.74 Xanthomonas_axonopodis.GCF_000266545  3433948 70.35 88.71 
3423581 69.73 Xanthomonas_axonopodis.GCF_000266485  3433517 70.34 88.7 
3427226 69.72 Xanthomonas_axonopodis.GCF_000266845  3436968 70.41 88.71 
3374248 69.68 Xanthomonas_axonopodis.GCF_000265625  3389165 69.43 88.75 
3423039 69.67 Xanthomonas_axonopodis.GCF_000266745  3432245 70.31 88.72 
3364535 69.64 Xanthomonas_axonopodis.GCF_000266185  3379192 69.23 88.79 
3401387 69.61 Xanthomonas_axonopodis.GCF_000266245  3414113 69.94 88.73 
3494600 69.59 Xanthomonas_arboricola.GCF_000306055  3497748 71.66 88.85 
3412101 69.59 Xanthomonas_axonopodis.GCF_000266765  3425490 70.18 88.72 
3424606 69.59 Xanthomonas_axonopodis.GCF_000265785  3437171 70.42 88.71 
3411483 69.57 Xanthomonas_axonopodis.GCF_000265685  3423933 70.14 88.73 
3425566 69.57 Xanthomonas_axonopodis.GCF_000266465  3434035 70.35 88.7 
3410500 69.56 Xanthomonas_axonopodis.GCF_000266085  3423524 70.14 88.73 
3290043 69.55 Xanthomonas_axonopodis.GCF_000266785  3303152 67.67 88.86 
3360530 69.53 Xanthomonas_axonopodis.GCF_000265965  3374661 69.13 88.78 
3423594 69.53 Xanthomonas_axonopodis.GCF_000266565  3434402 70.36 88.7 
3411148 69.52 Xanthomonas_axonopodis.GCF_000266165  3424010 70.15 88.73 
3411684 69.47 Xanthomonas_axonopodis.GCF_000265845  3426428 70.2 88.71 
3279812 69.45 Xanthomonas_axonopodis.GCF_000266525  3292370 67.45 88.78 
3438687 69.43 Xanthomonas_axonopodis.GCF_000265985  3448036 70.64 88.7 
3422447 69.39 Xanthomonas_axonopodis.GCF_000266325  3434269 70.36 88.7 
3648742 69.34 Xanthomonas_perforans.GCF_000192045  3435002 70.37 88.8 
3433330 69.33 Xanthomonas_axonopodis.GCF_000265585  3444908 70.57 88.72 
3309492 69.32 Xanthomonas_axonopodis.GCF_000265905  3323519 68.09 88.85 
3413380 69.23 Xanthomonas_axonopodis.GCF_000266145  3426468 70.2 88.73 
3442937 69.22 Xanthomonas_axonopodis.GCF_000309905  3454476 70.77 88.65 
3421346 69.17 Xanthomonas_axonopodis.GCF_000265765  3432924 70.33 88.7 
3174245 69.11 Xanthomonas_axonopodis.GCF_000265665  3189384 65.34 88.95 
3349134 69.01 Xanthomonas_axonopodis.GCF_000266125  3362790 68.89 88.81 
3430842 69 Xanthomonas_axonopodis.GCF_000266205  3439334 70.46 88.7 
3415913 68.94 Xanthomonas_axonopodis.GCF_000266665  3428629 70.24 88.71 
3362668 68.91 Xanthomonas_fuscans.GCF_000175135  3364440 68.93 88.72 
3285573 68.83 Xanthomonas_axonopodis.GCF_000265865  3300619 67.62 88.84 
3440136 68.58 Xanthomonas_axonopodis.GCF_000266705  3448387 70.65 88.7 
3392380 68.58 Xanthomonas_axonopodis.GCF_000285775  3398927 69.63 88.67 
3217502 68.56 Xanthomonas_campestris.GCF_000277875  3227335 66.12 88.47 
3440289 68.53 Xanthomonas_axonopodis.GCF_000266045  3449271 70.66 88.7 
3458796 68.46 Xanthomonas_hortorum.GCF_000505565  3458379 70.85 88.29 
3242204 68.43 Xanthomonas_axonopodis.GCF_000265705  3254668 66.68 88.89 
3425021 68.36 Xanthomonas_axonopodis.GCF_000266445  3432284 70.32 88.71 
3405714 68.3 Xanthomonas_axonopodis.GCF_000266605  3413109 69.92 88.74 
3214929 67.99 Xanthomonas_campestris.GCF_000277955  3223155 66.03 88.46 
3229866 67.97 Xanthomonas_campestris.GCF_000277915  3232569 66.22 88.42 
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3500220 67.92 Xanthomonas_axonopodis_Xac29_1_uid193774.NC_020800  3489867 71.49 88.69 
3445501 67.83 Xanthomonas_alfalfae.GCF_000488955  3450913 70.7 88.79 
3224364 67.76 Xanthomonas_campestris.GCF_000277895  3224951 66.07 88.41 
3395149 67.73 Xanthomonas_fuscans.GCF_000175155  3396203 69.58 88.73 
3425456 67.63 Xanthomonas_axonopodis.GCF_000266825  3437684 70.43 88.7 
3452428 67.46 Xanthomonas_axonopodis.GCF_000309925  3464660 70.98 88.65 
3730618 67.45 Xanthomonas_vesicatoria.GCF_000192025  3610523 73.97 88.94 
3486665 67.37 Xanthomonas_axonopodis_citri_306_uid57889.NC_003919  3490140 71.5 88.69 
3536912 67.33 Xanthomonas_axonopodis.GCF_000495275  3527850 72.27 88.66 
3258804 67.29 Xanthomonas_axonopodis.GCF_000266065  3270729 67.01 88.87 
3425828 67.02 Xanthomonas_citri.GCF_000263335  3436894 70.41 88.66 
3231561 66.96 Xanthomonas_vasicola.GCF_000278035  3235516 66.28 88.45 
3498283 66.93 Xanthomonas_arboricola.GCF_000355635  3496237 71.63 88.91 
3282758 66.89 Xanthomonas_campestris.GCF_000233635  3215723 65.88 88.49 
3426184 66.81 Xanthomonas_axonopodis.GCF_000265605  3434495 70.36 88.71 
3199446 66.76 Xanthomonas_campestris.GCF_000277975  3201415 65.59 88.53 
3440203 66.43 Xanthomonas_campestris_vesicatoria_85_10_uid58321.NC_007508  3436431 70.4 88.77 
3177476 66.28 Xanthomonas_campestris.GCF_000159815  3191469 65.38 88.33 
3486665 66.11 Xanthomonas_citri.GCF_000007165  3490140 71.5 88.69 
3500220 66.09 Xanthomonas_axonopodis.GCF_000348585  3489867 71.49 88.69 
3259839 65.97 Xanthomonas_campestris.GCF_000221965  3235136 66.28 87.78 
3259839 65.97 Xanthomonas_campestris_raphani_756C_uid159539.NC_017271  3235136 66.28 87.78 
3510122 65.96 Xanthomonas_citri_Aw12879_uid194444.NC_020815  3504578 71.8 88.67 
3122181 65.84 Xanthomonas_campestris.GCF_000277935  3123091 63.98 88.22 
2856081 65.75 Xanthomonas_oryzae.GCF_000511585  2865786 58.71 88.55 
3632228 65.7 Xanthomonas_gardneri.GCF_000192065  3409330 69.84 88.39 
3447860 65.41 Xanthomonas_cassavae.GCF_000454545  3464534 70.98 89.16 
3444615 65.41 Xanthomonas_axonopodis.GCF_000259445  3446198 70.6 88.75 
3510122 65.02 Xanthomonas_citri.GCF_000349225  3504578 71.8 88.67 
2779966 64.87 Xanthomonas_oryzae.GCF_000482445  2786277 57.08 88.56 
3204799 64.64 Xanthomonas_vasicola.GCF_000278015  3212538 65.81 88.42 
3199708 64.62 Xanthomonas_vasicola.GCF_000277995  3206648 65.69 88.41 
3094619 64.42 Xanthomonas_vasicola.GCF_000278075  3096324 63.43 88.63 
2837982 64.24 Xanthomonas_oryzae.GCF_000507025  2851686 58.42 88.58 
3216393 64.03 Xanthomonas_campestris.GCF_000263835  3218504 65.94 87.78 
3245426 63.9 Xanthomonas_campestris.GCF_000070605  3223488 66.04 87.77 
3245426 63.9 Xanthomonas_campestris_uid61643.NC_010688  3223488 66.04 87.77 
3189992 63.78 Xanthomonas_campestris.GCF_000321125  3198870 65.53 87.73 
2925863 63.75 Xanthomonas_oryzae.GCF_000212755  2940610 60.24 88.6 
3225566 63.54 Xanthomonas_campestris.GCF_000007145  3215592 65.88 87.73 
3225566 63.54 Xanthomonas_campestris_ATCC_33913_uid57887.NC_003902  3215592 65.88 87.73 
3443225 63.53 Xanthomonas_euvesicatoria.GCF_000009165  3437634 70.42 88.77 
2898804 63.09 Xanthomonas_oryzae.GCF_000212775  2911183 59.64 88.66 
3224075 62.62 Xanthomonas_campestris.GCF_000012105  3210905 65.78 87.72 
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3224075 62.62 Xanthomonas_campestris_8004_uid57595.NC_007086  3210905 65.78 87.72 
2928763 60.62 Xanthomonas_oryzae.GCF_000168315  2876862 58.94 88.53 
2928763 60.62 Xanthomonas_oryzae_oryzicola_BLS256_uid54411.NC_017267  2876862 58.94 88.53 
2994263 60.48 Xanthomonas_vasicola.GCF_000278055  2992850 61.31 88.81 
2519966 60.25 Xanthomonas_fragariae.GCF_000376745  2480723 50.82 87.58 
3217719 58.74 Xanthomonas_vasicola.GCF_000159795  3224905 66.07 88.41 
2872100 58.14 Xanthomonas_oryzae_MAFF_311018_uid58547.NC_007705  2791472 57.19 88.55 
2872100 58.14 Xanthomonas_oryzae.GCF_000010025  2791472 57.19 88.55 
2866762 58.01 Xanthomonas_oryzae_KACC_10331_uid58155.NC_006834  2790542 57.17 88.55 
2866762 58.01 Xanthomonas_oryzae.GCF_000007385  2790542 57.17 88.55 
2979829 56.87 Xanthomonas_oryzae_PXO99A_uid59131.NC_010717  2793070 57.22 88.55 
2979829 56.87 Xanthomonas_oryzae.GCF_000019585  2793070 57.22 88.55 
2309083 46.5 Xanthomonas_sp._M97.GCF_000401255  2313467 47.39 86.24 
1437893 35.06 Xanthomonas_translucens.GCF_000313775  1444452 29.59 85.42 
1484597 33.23 Xanthomonas_translucens.GCF_000334075  1481033 30.34 85.27 
1472756 32.99 Xanthomonas_translucens.GCF_000331775  1470877 30.13 85.4 
1515567 32.21 Xanthomonas_sp._SHU166.GCF_000364685  1513699 31.01 85.35 
1571991 32.09 Xanthomonas_sacchari.GCF_000225975  1566458 32.09 85.25 
1185367 32.02 Xanthomonas_sp._NCPPB1131.GCF_000226895  1185379 24.28 86.08 
1545738 31.96 Xanthomonas_sp._SHU199.GCF_000364665  1540783 31.57 85.31 
1551429 31.95 Xanthomonas_sp._SHU308.GCF_000364645  1549168 31.74 85.3 
1466854 31.55 Xanthomonas_sp._NCPPB1132.GCF_000226915  1462817 29.97 85.54 
722661 21.14 Pseudoxanthomonas_suwonensis_11_1_uid62105.NC_014924  716302 14.67 84.41 
686299 19.88 Pseudoxanthomonas_spadix_BD_a59_uid75113.NC_016147  685905 14.05 84.42 
714597 18.96 Xanthomonas_albilineans_GPE_PC73_uid43163.NC_013722  710312 14.55 84.63 







Supplementary table 1: Summary of results of dnadiff comparisons between the 







1. Cheung, M. K., Li, L., Nong, W. & Kwan, H. S. 2011 German Escherichia coli 
O104:H4 outbreak: whole-genome phylogeny without alignment. BMC Res. 
Notes 4, 533 (2011). 
2. Quick, J. et al. Real-time, portable genome sequencing for Ebola surveillance. 
Nature 530, 228–32 (2016). 
3. Jacobs, J. M., Pesce, C., Lefeuvre, P. & Koebnik, R. Comparative genomics of 
a cannabis pathogen reveals insight into the evolution of pathogenicity in 
Xanthomonas. 6, 1–13 (2015). 
4. Sullivan, M. J., Petty, N. K. & Beatson, S. A. Easyfig: a genome comparison 












Work from this chapter was published in:  
  
Laver, T., Harrison, J., O'Neill, P. A., Moore, K., Farbos, A., Paszkiewicz, K., & 
Studholme, D. J. (2015). Assessing the performance of the Oxford Nanopore 
Technologies MinION. Biomolecular detection and quantification, 3, 1–8.  
 
 
This paper was cited by: 
 
1. Rhoads, A. & Au, K. F. PacBio Sequencing and Its Applications. Genomics, Proteomics 
Bioinforma. 13, 278–289 (2015). 
2. Wattam, A. R. et al. Improvements to PATRIC, the all-bacterial bioinformatics database and 
analysis resource center. Nucleic Acids Res. 45, D535–D542 (2017). 
3. Sović, I. et al. Fast and sensitive mapping of nanopore sequencing reads with GraphMap. 
Nat. Commun. 7, (2016). 
4. Ye, C., Hill, C. M., Wu, S., Ruan, J. & Ma, Z. DBG2OLC: Efficient assembly of large 
genomes using long erroneous reads of the third generation sequencing technologies. Sci. 
Rep. 6, 1–9 (2016). 
5. Marschall, T. et al. Computational pan-genomics: Status, promises and challenges. Brief. 
Bioinform. 19, 118–135 (2018). 
6. Bleidorn, C. Third generation sequencing: Technology and its potential impact on 
evolutionary biodiversity research. Syst. Biodivers. 14, 1–8 (2016). 
7. Gomez-Escribano, J. P., Alt, S. & Bibb, M. J. Next generation sequencing of actinobacteria 
for the discovery of novel natural products. Mar. Drugs 14, 6–8 (2016). 
8. Salmela, L., Walve, R., Rivals, E., Ukkonen, E. & Sahinalp, C. Accurate self-correction of 
160 
 
errors in long reads using de Bruijn graphs. Bioinformatics 33, 799–806 (2017). 
9. Ambardar, S., Gupta, R., Trakroo, D., Lal, R. & Vakhlu, J. High Throughput Sequencing: An 
Overview of Sequencing Chemistry. Indian J. Microbiol. 56, 394–404 (2016). 
10. Cretu Stancu, M. et al. Mapping and phasing of structural variation in patient genomes 
using nanopore sequencing. Nat. Commun. 8, 1–13 (2017). 
11. Rang, F. J., Kloosterman, W. P. & de Ridder, J. From squiggle to basepair: Computational 
approaches for improving nanopore sequencing read accuracy. Genome Biol. 19, 1–11 
(2018). 
12. Sohn, J. Il & Nam, J. W. The present and future of de novo whole-genome assembly. Brief. 
Bioinform. 19, 23–40 (2018). 
13. Sunagar, K., Morgenstern, D., Reitzel, A. M. & Moran, Y. Ecological venomics: How 
genomics, transcriptomics and proteomics can shed new light on the ecology and evolution 
of venom. J. Proteomics 135, 62–72 (2016). 
14. Kennedy, E., Dong, Z., Tennant, C. & Timp, G. Reading the primary structure of a protein 
with 0.07 nm 3 resolution using a subnanometre-diameter pore. Nat. Nanotechnol. 11, 968–
976 (2016). 
15. Dodsworth, S. Genome skimming for next-generation biodiversity analysis. Trends Plant 
Sci. 20, 525–527 (2015). 
16. Weirather, J. L. et al. Comprehensive comparison of Pacific Biosciences and Oxford 
Nanopore Technologies and their applications to transcriptome analysis. F1000Research 6, 
100 (2017). 
17. Escalona, M., Rocha, S. & Posada, D. A comparison of tools for the simulation of genomic 
next-generation sequencing data. Nat. Rev. Genet. 17, 459–469 (2016). 
18.  Camilla, L.C. et al. MinION Analysis and Reference Consortium: Phase 1 data release and 
analysis. F1000Research 4, 1075 (2015). 
161 
 
19. Hugerth, L. W. & Andersson, A. F. Analysing microbial community composition through 
amplicon sequencing: From sampling to hypothesis testing. Front. Microbiol. 8, 1–22 
(2017). 
20. Frenken, T. et al. Integrating chytrid fungal parasites into plankton ecology: research gaps 
and needs. Environ. Microbiol. 19, 3802–3822 (2017). 
21. Lee, R. S. & Behr, M. A. The implications of whole-genome sequencing in the control of 
tuberculosis. Ther. Adv. Infect. Dis. 3, 47–62 (2015). 
22. Paridah, M. . et al. We are IntechOpen , the world ’ s leading publisher of Open Access 
books Built by scientists , for scientists TOP 1 %. Intech i, 13 (2016). 
23. Kchouk, M., Gibrat, J. F. & Elloumi, M. Generations of Sequencing Technologies: From 
First to Next Generation. Biol. Med. 09, (2017). 
24. Stoiber, M. et al. De novo Identification of DNA Modifications Enabled by Genome-Guided 
Nanopore Signal Processing. bioRxiv 094672 (2016).  
25. Friedrich, S. M., Zec, H. C. & Wang, T. H. Analysis of single nucleic acid molecules in 
micro- and nano-fluidics. Lab Chip 16, 790–811 (2016). 
26. Owens, M. M. et al. Pitfalls of haplotype phasing from amplicon-based long-read 
sequencing. Sci. Rep. 6, 1–6 (2016). 
27. Liu, Q., Zhang, P., Wang, D., Gu, W. & Wang, K. Interrogating the ‘unsequenceable’ 
genomic trinucleotide repeat disorders by long-read sequencing. Genome Med. 9, 65 
(2017). 
28. Magi, A., Semeraro, R., Mingrino, A., Giusti, B. & D’Aurizio, R. Nanopore sequencing data 
analysis: State of the art, applications and challenges. Brief. Bioinform. 19, 1256–1272 
(2017). 
29. Mitsuhashi, S. et al. A portable system for rapid bacterial composition analysis using a 
nanopore-based sequencer and laptop computer. Sci. Rep. 7, 5657 (2017). 
162 
 
30. Mak, S. S. T. et al. Comparative performance of the BGISEQ-500 vs Illumina HiSeq2500 
sequencing platforms for palaeogenomic sequencing. Gigascience 6, 1–13 (2017). 
31. Parker, J., Helmstetter, A. J., Devey, Di., Wilkinson, T. & Papadopulos, A. S. T. Field-based 
species identification of closely-related plants using real-time nanopore sequencing. Sci. 
Rep. 7, 8345 (2017). 
32. Chu, J., Mohamadi, H., Warren, R. L., Yang, C. & Birol, I. Innovations and challenges in 
detecting long read overlaps: An evaluation of the state-of-the-art. Bioinformatics 33, 1261–
1270 (2017). 
33. Tomaszkiewicz, M., Medvedev, P. & Makova, K. D. Y and W Chromosome Assemblies: 
Approaches and Discoveries. Trends Genet. 33, 266–282 (2017). 
34. Sović, I., Križanović, K., Skala, K. & Šikić, M. Evaluation of hybrid and non-hybrid methods 
for de novo assembly of nanopore reads. Bioinformatics 32, 2582–2589 (2016). 
35. Jansson, J. K., White, R. A., Baker, E. S., Callister, S. J. & Moore, R. J. The past, present 
and future of microbiome analyses. Nat. Protoc. 11, 2049–2053 (2016). 
36. Amha, Y. M. et al. Inhibition of anaerobic digestion processes: Applications of molecular 
tools. Bioresour. Technol. 247, 999–1014 (2018). 
37. Deschamps, S. et al. Characterization, correction and de novo assembly of an Oxford 
Nanopore genomic dataset from Agrobacterium tumefaciens. Sci. Rep. 6, 28625 (2016). 
38. Hossein TabatabaeiYazdi, S. M., Gabrys, R. & Milenkovic, O. Portable and Error-Free 
DNA-Based Data Storage. Sci. Rep. 7, 5011 (2017). 
39. Zhang, D., Bi, H., Liu, B. & Qiao, L. Detection of Pathogenic Microorganisms by 
Microfluidics Based Analytical Methods. Anal. Chem. 90, 5512–5520 (2018). 
40. Križanović, K., Echchiki, A., Roux, J. & Šikić, M. Evaluation of tools for long read RNA-seq 
splice-aware alignment. Bioinformatics 34, 748–754 (2018). 
41. Ye, C. & Ma, Z. (Sam). Sparc: a sparsity-based consensus algorithm for long erroneous 
163 
 
sequencing reads. PeerJ 4, e2016 (2016). 
42. Moldován, N. et al. Third-generation Sequencing Reveals Extensive Polycistronism and 
Transcriptional Overlapping in a Baculovirus. Sci. Rep. 8, 8604 (2018). 
43. Massaia, A. & Xue, Y. Human Y chromosome copy number variation in the next generation 
sequencing era and beyond. Hum. Genet. 136, 591–603 (2017). 
44. Debladis, E., Llauro, C., Carpentier, M. C., Mirouze, M. & Panaud, O. Detection of active 
transposable elements in Arabidopsis thaliana using Oxford Nanopore Sequencing 
technology. BMC Genomics 18, 537 (2017). 
45. Pomerantz, A. et al. Real-time DNA barcoding in a rainforest using nanopore sequencing: 
Opportunities for rapid biodiversity assessments and local capacity building. Gigascience 7, 
1–14 (2018). 
46. Lear, G. et al. Methods for the extraction, storage, amplification and sequencing of DNA 
from environmental samples. N. Z. J. Ecol. 42, 10-50A (2018). 
47. Carter, J.-M. & Hussain, S. Robust long-read native DNA sequencing using the ONT CsgG 
Nanopore system. Wellcome open Res. 2, 23 (2017). 
48. Alvarenga, D. O., Fiore, M. F. & Varani, A. M. A metagenomic approach to cyanobacterial 
genomics. Frontiers in Microbiology 8, 809 (2017). 
49. Barrett, C. F., Bacon, C. D., Antonelli, A., Cano, Á. & Hofmann, T. An introduction to plant 
phylogenomics with a focus on palms. Bot. J. Linn. Soc. 182, 234–255 (2016). 
50. Wilkinson, M. J. et al. Supplementary Information Replacing Sanger with Next Generation 
Sequencing to improve coverage and quality of reference DNA barcodes for plants 
Supplementary Tables S1 , S2 , S3 , S4 , S5 , S6. Sci. Rep. 7, 46040 (2017). 
51. Moldován, N. et al. Multi-platform sequencing approach reveals a novel transcriptome 
profile in pseudorabies virus. Frontiers in Microbiology 8, 2708 (2018). 
52. Nguyen, M. et al. Developing an in silico minimum inhibitory concentration panel test for 
164 
 
Klebsiella pneumonia. Sci. Rep. 8, 421 (2018). 
53. Alikian, M., Gale, R. P., Apperley, J. F., Foroni, L. & Alikian, M. Molecular techniques for the 
personalised management of patients with chronic myeloid leukaemia. Biomol. Detect. 
Quantif. 11, 4–20 (2017). 
54. Agah, S., Zheng, M., Pasquali, M. & Kolomeisky, A. B. DNA sequencing by nanopores: 
Advances and challenges. J. Phys. D. Appl. Phys. 49, 413001 (2016). 
55. Van den Bergh, B., Swings, T., Fauvart, M. & Michiels, J. Experimental Design, Population 
Dynamics, and Diversity in Microbial Experimental Evolution. Microbiol. Mol. Biol. Rev. 82, 
e00008-18 (2018). 
56. Valles-Colomer, M. et al. Meta-omics in inflammatory bowel disease research: Applications, 
challenges, and guidelines. J. Crohn’s Colitis 10, 735–746 (2016). 
57. Lavezzo, E., Barzon, L., Toppo, S. & Palù, G. Third generation sequencing technologies 
applied to diagnostic microbiology: benefits and challenges in applications and data 
analysis. Expert Rev. Mol. Diagn. 16, 1011–1023 (2016). 
58. Vasylyeva, T. I., Friedman, S. R., Paraskevis, D. & Magiorkinis, G. Integrating molecular 
epidemiology and social network analysis to study infectious diseases: Towards a socio-
molecular era for public health. Infect. Genet. Evol. 46, 248–255 (2016). 
59. Jünemann, S. et al. Bioinformatics for NGS-based metagenomics and the application to 
biogas research. J. Biotechnol. 261, 10–23 (2017). 
60. Merker, M., Kohl, T. A., Niemann, S. & Supply, P. The evolution of strain typing in the 
mycobacterium tuberculosis complex. in Advances in Experimental Medicine and Biology 
1019, 43–78 (Springer, 2017). 
61. D’Agostino, D., Morganti, L., Corni, E., Cesini, D. & Merelli, I. Combining Edge and Cloud 
computing for low-power, cost-effective metagenomics analysis. Futur. Gener. Comput. 
Syst. 90, 79–85 (2019). 
165 
 
62. White, R. A. et al. The state of rhizospheric science in the era of multi-omics: A practical 
guide to omics technologies. Rhizosphere 3, 212–221 (2017). 
63. Ma, X., Stachler, E. & Bibby, K. Evaluation of Oxford Nanopore MinION Sequencing for 16S 
rRNA Microbiome Characterization (preprint). bioRxiv 099960 (2017).  
64. Amin, M. R., Skiena, S. & Schatz, M. C. NanoBLASTer: Fast alignment and 
characterization of Oxford Nanopore single molecule sequencing reads. in 2016 IEEE 6th 
International Conference on Computational Advances in Bio and Medical Sciences, 
ICCABS 2016 1–6 (IEEE, 2016).  
65. Deonovic, B., Wang, Y., Weirather, J., Wang, X. J. & Au, K. F. IDP-ASE: Haplotyping and 
quantifying allele-specific expression at the gene and gene isoform level by hybrid 
sequencing. Nucleic Acids Res. 45, e32–e32 (2017). 
66. Zhao, C., Liu, F. & Pyle, A. M. An ultraprocessive, accurate reverse transcriptase encoded 
by a metazoan group II intron. Rna 24, 183–185 (2018). 
67. Liu, M. & Darling, A. Metagenomic Chromosome Conformation Capture (3C): techniques, 
applications, and challenges. F1000Research 4, 1377 (2015). 
68. Adams, I. & Fox, A. Diagnosis of plant viruses using next-generation sequencing and 
metagenomic analysis. in Current Research Topics in Plant Virology 323–335 (Springer, 
2016).  
69. Morrison, J., Watts, G., Hobbs, G. & Dawnay, N. Field-based detection of biological 
samples for forensic analysis: Established techniques, novel tools, and future innovations. 
Forensic Sci. Int. 285, 147–160 (2018). 
70. Brady, K. T. & Reiner, J. E. Improving the prospects of cleavage-based nanopore 
sequencing engines. J. Chem. Phys. 143, 08B608_1 (2015). 
71. Redin, D. et al. Droplet Barcode Sequencing for targeted linked-read haplotyping of single 
DNA molecules. Nucleic Acids Res. 45, e125–e125 (2017). 
166 
 
72. Galata, V. et al. BusyBee Web: metagenomic data analysis by bootstrapped supervised 
binning and annotation. Nucleic Acids Res. 45, W171–W179 (2017). 
73. Doyle, L. E. & Marsili, E. Weak electricigens: A new avenue for bioelectrochemical 
research. Bioresour. Technol. 258, 354–364 (2018). 
74. Lindberg, M. R. et al. A comparison and integration of MiSeq and MinION platforms for 
sequencing single source and mixed mitochondrial genomes. PLoS One 11, e0167600 
(2016). 
75. Austin, C. M. et al. De novo genome assembly and annotation of Australia’s largest 
freshwater fish, the Murray cod (Maccullochella peelii), from Illumina and Nanopore 
sequencing read. Gigascience 6, gix063 (2017). 
76. Krishnakumar, R. et al. Systematic and stochastic influences on the performance of the 
MinION nanopore sequencer across a range of nucleotide bias. Sci. Rep. 8, 3159 (2018). 
77. Fu, S. et al. IDP-denovo: De novo transcriptome assembly and isoform annotation by hybrid 
sequencing. Bioinformatics 34, 2168–2176 (2018). 
78. Jagadeesan, B. et al. The use of next generation sequencing for improving food safety: 
Translation into practice. Food Microbiol. 79, 96–115 (2019). 
79. Weik, F., Kesselheim, S. & Holm, C. A coarse-grained DNA model for the prediction of 
current signals in DNA translocation experiments. J. Chem. Phys. 145, 194106 (2016). 
80. Di Donato, A., Filippone, E., Ercolano, M. R. & Frusciante, L. Genome Sequencing of 
Ancient Plant Remains: Findings, Uses and Potential Applications for the Study and 
Improvement of Modern Crops. Front. Plant Sci. 9, 441 (2018). 
81. Szkop, K. J. & Nobeli, I. Untranslated Parts of Genes Interpreted: Making Heads or Tails of 
High-Throughput Transcriptomic Data via Computational Methods. BioEssays 39, 1700090 
(2017). 
82. Arnold, C. Considerations in centralizing whole genome sequencing for microbiology in a 
167 
 
public health setting. Expert Review of Molecular Diagnostics 16, 619–621 (2016). 
83. Krachunov, M., Nisheva, M. & Vassilev, D. Application of Machine Learning Models in Error 
and Variant Detection in High-Variation Genomics Datasets. Computers 6, 29 (2017). 
84. Cook, D. E. et al. Long-Read Annotation: Automated Eukaryotic Genome Annotation Based 
on Long-Read cDNA Sequencing. Plant Physiol. 179, 38–54 (2019). 
85. Ji, W. et al. Rapid and Accurate Sequencing of Enterovirus Genomes Using MinION 
Nanopore Sequencer *. Biomed Env. Sci 30, 718–726 (2017). 
86. Helbing, S., Lattorff, H. M. G., Moritz, R. F. A. & Buttstedt, A. Comparative analyses of the 
major royal jelly protein gene cluster in three Apis species with long amplicon sequencing. 
DNA Res. 24, 279–287 (2017). 
87. Siegler, R. A New Conceptual Framework for Sarcoma. Front. Genet. 6, 257–260 (2015). 
88. Magner, A., Duda, J., Szpankowski, W. & Grama, A. Fundamental Bounds for Sequence 
Reconstruction From Nanopore Sequencers. IEEE Trans. Mol. Biol. Multi-Scale Commun. 
2, 92–106 (2017). 
89. Zhao QiongYi, and Gratten, J., and Restuadi Restuadi & and Li Xuan. Mapping and 
differential expression analysis from short-read RNA-Seq data in model organisms. Quant. 
Biol. 4, 22–35 (2016). 
90. Hu, H., Scheben, A. & Edwards, D. Advances in Integrating Genomics and Bioinformatics in 
the Plant Breeding Pipeline. Agriculture 8, 75 (2018). 
91. Susilawati, T. N. et al. Deep sequencing approach for investigating infectious agents 
causing fever. Eur. J. Clin. Microbiol. Infect. Dis. 35, 1137–1149 (2016). 
92. Gonzalez, C. et al. Barcoding analysis of HIV drug resistance mutations using Oxford 
Nanopore MinION (ONT) sequencing. bioRxiv 240077 (2018).  
93. Moldován, N. et al. Multiplatform next-generation sequencing identifies novel RNA 
molecules and transcript isoforms of the endogenous retrovirus isolated from cultured cells. 
168 
 
FEMS Microbiol. Lett. 365, fny013 (2018). 
94. van Aerle, R. & Santos, E. M. Advances in the application of high-throughput sequencing in 
invertebrate virology. J. Invertebr. Pathol. 147, 145–156 (2017). 
95. Maggi, E., Patterson, N. E. & Montagna, C. Technological advances in precision medicine 
and drug development. Expert Rev. Precis. Med. Drug Dev. 1, 331–343 (2016). 
96. Fu, S., Wang, A. & Au, K. F. A comparative evaluation of hybrid error correction methods 
for error-prone long reads. Genome Biol. 20, 26 (2019). 
97. Rice, E. S. & Green, R. E. New Approaches for Genome Assembly and Scaffolding. Annu. 
Rev. Anim. Biosci. 7, 17–40 (2018). 
98. Song, E. J., Lee, E. S. & Nam, Y. Do. Progress of analytical tools and techniques for human 
gut microbiome research. J. Microbiol. 56, 693–705 (2018). 
99. Parker, J., Helmstetter, A. J., Devey, D. S. & Papadopulos, A. S. T. Field-based species 
identification in eukaryotes using single molecule, real-time sequencing. bioRxiv 107656 
(2017). 
100. Van den Berge, K. et al. RNA Sequencing Data: Hitchhiker’s Guide to Expression Analysis. 
Annu. Rev. Biomed. Data Sci. 2, (2019). 
101. Cali, D. S., Kim, J. S., Ghose, S., Alkan, C. & Mutlu, O. Nanopore Sequencing Technology 
and Tools for Genome Assembly: Computational Analysis of the Current State, Bottlenecks 
and Future Directions. arXiv Prepr. arXiv 1711, (2017). 
102. Bainomugisa, A. et al. A complete high-quality MinION nanopore assembly of an 
extensively drug-resistant Mycobacterium tuberculosis Beijing lineage strain identifies novel 
variation in repetitive PE/PPE gene regions. Microb. Genomics 4, (2018). 
103. Macqueen, D. J. et al. Nanopore sequencing for rapid diagnostics of salmonid RNA viruses. 
Sci. Rep. 8, 1–9 (2018). 
104. Milicchio, F. & Prosperi, M. Efficient data structures for mobile de novo genome assembly 
169 
 
by third-generation sequencing. Procedia Comput. Sci. 110, 440–447 (2017). 
105. Krachunov, M., Nisheva, M. & Vassilev, D. Machine learning-driven noise separation in high 
variation genomics sequencing datasets. in Lecture Notes in Computer Science (including 
subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 11089 
LNAI, 173–185 (Springer, 2018). 
106. Brenner, J. & Putonti, C. HAsh-MaP-ERadicator: Filtering non-target sequences from next 
generation sequencing reads. in Proceedings - 2015 IEEE International Conference on 
Bioinformatics and Biomedicine, BIBM 2015 1100–1101 (IEEE, 2015).  
107. Lecluze, E., Jégou, B., Rolland, A. D. & Chalmel, F. New transcriptomic tools to understand 
testis development and functions. Mol. Cell. Endocrinol. 468, 47–59 (2018). 
108. Afshar, P. T. & Wong, W. H. COSINE: non-seeding method for mapping long noisy 
sequences. Nucleic Acids Res. 45, e132 (2017). 
109. Samson, R. et al. Metagenomic insights to understand transient influence of Yamuna River 
on taxonomic and functional aspects of bacterial and archaeal communities of River 
Ganges. Sci. Total Environ. 674, 288–299 (2019). 
110. Patel, A. et al. MinION rapid sequencing: Review of potential applications in neurosurgery. 
Surg. Neurol. Int. 9, 157 (2018). 
111. Starostik, P. Clinical mutation assay of tumors. Anticancer. Drugs 28, 1–10 (2017). 
112. Owen, S. V, Perez-Sepulveda, B. M. & Adriaenssens, E. M. Detection of Bacteriophages: 
Sequence-Based Systems. Bacteriophages Biol. Technol. Ther. 1–25 (2018). 
113. Cali, D. S., Kim, J. S., Ghose, S., Alkan, C. & Mutlu, O. Nanopore Sequencing Technology 
and Tools for Genome Assembly: Computational Analysis of the Current State, Bottlenecks 
and Future Directions. in Pacific Symposium on Biocomputing Poster Session (2017).  
114. Chu, J. Overlapping long sequence reads: Current in- novations and challenges in 
developing sensi- tive, specific and scalable algorithms. Bioarxiv 1–3 (2016).  
170 
 
115. Faucon, P., Trevino, R., Balachandran, P., Standage-Beier, K. & Wang, X. High Accuracy 
Base Calls in Nanopore Sequencing. in Proceedings of the 6th International Conference on 
Bioinformatics and Biomedical Science 12–16 (ACM, 2017).  
116. Corni, E. et al. Low-power portable devices for metagenomics analysis: Fog computing 
makes bioinformatics ready for the Internet of Things. Futur. Gener. Comput. Syst. 88, 467–
478 (2018). 
117. Yeh, C.-M., Liu, Z.-J. & Tsai, W.-C. Advanced Applications of Next-Generation Sequencing 
Technologies to Orchid Biology. Curr. Issues Mol. Biol. 51–70 (2018).  
118. Hu, Y. O. O. et al. Stationary and portable sequencing-based approaches for tracing 
wastewater contamination in urban stormwater systems. Sci. Rep. 8, 11907 (2018). 
119. Zhao, F. & Bajic, V. B. The Value and Significance of Metagenomics of Marine 
Environments. Genomics, Proteomics Bioinforma. 13, 271–274 (2015). 
120. Yamazaki, H., Esashika, K. & Saiki, T. A 150 nm ultraviolet excitation volume on a porous 
silicon membrane for direct optical observation of dna coil relaxation during capture into 
nanopores. Nano Futur. 1, 11001 (2017). 
121. Stein, D. Nanopore Sequencing: Forcing Improved Resolution. Biophys. J. 109, 2001–2002 
(2015). 
122. Yanagi, I., Hamamura, H., Akahori, R. & Takeda, K. I. Two-step breakdown of a SiN 
membrane for nanopore fabrication: Formation of thin portion and penetration. Sci. Rep. 8, 
(2018). 
123. Rau, T., Weik, F. & Holm, C. A dsDNA model optimized for electrokinetic applications. Soft 
Matter 13, 3918–3926 (2017). 
124. Huang, Y. C., Dang, V. D., Chang, N. C. & Wang, J. Multiple large inversions and 
breakpoint rewiring of gene expression in the evolution of the fire ant social supergene. 
Proc. R. Soc. B Biol. Sci. 285, 20180221 (2018). 
171 
 
125. Lewandowski, K. et al. The Effect of Nucleic Acid Extraction Platforms and Sample Storage 
on the Integrity of Viral RNA for Use in Whole Genome Sequencing. J. Mol. Diagnostics 19, 
303–312 (2017). 
126. Bleidorn, C. & Bleidorn, C. Assembly and Data Quality. in Phylogenomics 81–103 
(Springer, 2017).  
127. Baldwin-Brown, J. G., Weeks, S. C. & Long, A. D. A New Standard for Crustacean 
Genomes: The Highly Contiguous, Annotated Genome Assembly of the Clam Shrimp 
Eulimnadia texana Reveals HOX Gene Order and Identifies the Sex Chromosome. 
Genome Biol. Evol. 10, 143–156 (2017). 
128. Delehelle, F., Cussat-Blanc, S., Alliot, J. M., Luga, H. & Balaresque, P. ASGART: Fast and 
parallel genome scale segmental duplications mapping. Bioinformatics 34, 2708–2714 
(2018). 
129. Dutta, G. et al. Microfluidic Devices for Label-Free DNA Detection. Chemosensors 6, 43 
(2018). 
130. Kaplan, R., Yavits, L. & Ginosar, R. RASSA: Resistive Pre-Alignment Accelerator for 
Approximate DNA Long Read Mapping. IEEE Micro (2018).  
131. H., G. & G., M. T. Next-generation sequencing platforms for latest livestock reference 
genome assemblies. African J. Biotechnol. 17, 1232–1240 (2018). 
132. Arango-Argoty, G. A. et al. NanoARG: a web service for detecting and contextualizing 
antimicrobial resistance genes from nanopore-derived metagenomes. Microbiome 7, 88 
(2019). 
133. Najafi, A. et al. Fundamental Limits of Pooled-DNA Sequencing. arXiv Prepr. 
arXiv1604.04735 (2016). 
134.  Radko, S. P. et al. Prospects for the use of third generation sequencers for quantitative 
profiling of transcriptome. Biomed. Chem. Res. Methods 1, e00086 (2018). 
172 
 
135. Hansen, S. et al. Combination random isothermal amplification and nanopore sequencing 
for rapid identification of the causative agent of an outbreak. J. Clin. Virol. 106, 23–27 
(2018). 
136. Horbal, L. & Luzhetskyy, A. The Genetic System of Actinobacteria. in Biology and 
Biotechnology of Actinobacteria 79–121 (Springer, 2017). -1_5 
137. Kaplan, R., Yavits, L. & Ginosar, R. RASSA: Resistive Pre-Alignment Accelerator for 
Approximate DNA Long Read Mapping. IEEE Micro (2018).  
138. Hehir-kwa, J. Y., Tops, B. B. J., Kemmeren, P., Tops, B. B. J. & The, P. K. Expert Review of 
Molecular Diagnostics The clinical implementation of copy number detection in the age of 
next-generation sequencing. Expert Rev. Mol. Diagn. 18, 907–915 (2018). 
139. Handler, K. et al. Single-Cell Transcriptomics in Cancer Immunobiology: The Future of 
Precision Oncology. Front. Immunol. 9, 2582 (2018). 
140. Karaca, M. & Ince, A. G. Molecular markers in Salvia L.: Past, present and future. in Salvia 
Biotechnology 291–398 (Springer, 2018).  
141. Arango-Argoty, G. A. et al. NanoARG: A web service for identification of antimicrobial 
resistance elements from nanopore-derived environmental metagenomes. bioRxiv 483248 
(2018).  
142. Harel, N., Meir, M., Gophna, U. & Stern, A. Sequencing Complete Genomes of RNA 
Viruses With MinION Nanopore: Finding Associations Between Mutations. bioRxiv 575480 
(2019).  
143. Druley, T. E. Minimal Residual Disease Testing. Minimal Residual Dis. Test. (2018).  
144. Suwinski, P. et al. Advancing Personalized Medicine Through the Application of Whole 
Exome Sequencing and Big Data Analytics. Front. Genet. 10, 49 (2019). 
145. Nellist, C. F. Disease Resistance in Polyploid Strawberry. in The Genomes of Rosaceous 
Berries and Their Wild Relatives 79–94 (Springer, 2018).  
173 
 
146. Gilchrist, C. A. The E. histolytica Genome Structure and Virulence. Curr. Trop. Med. 
Reports 3, 158–163 (2016). 
147. Krizanovic, K., Sovic, I., Krpelnik, I. & Sikic, M. RNA Transcriptome Mapping with 
GraphMap. in bioRxiv (2017).  
148. Franus, W., Nowak, R. M. & Kuśmirek, W. Scaffolding algorithm using second- and third-
generation reads. in Photonics Applications in Astronomy, Communications, Industry, and 
High-Energy Physics Experiments 2018 10808, 82 (International Society for Optics and 
Photonics, 2018). 
149. Walsh, D. M. et al. the Airway Microbiome After Burn and Inhalation Injury. Chapel Hill 
(2016). 
150. Nowak, R. M., Forc, M. & Kuśmirek, W. De Novo genome assembly for third generation 
sequencing data. in Photonics Applications in Astronomy, Communications, Industry, and 
High-Energy Physics Experiments 2018 10808, 112 (International Society for Optics and 
Photonics, 2018). 
151. Jahn, S. C. & Starostik, P. Clinical Lung Cancer Mutation Detection. A Glob. Sci. Vis. - 
Prev. Diagnosis, Treat. Lung Cancer 83 (2017).  
152. Zascavage, R. R., Thorson, K. & Planz, J. V. Nanopore sequencing: An enrichment-free 
alternative to mitochondrial DNA sequencing. Electrophoresis 40, 272–280 (2019). 
153. Dufort y Álvarez, G. et al. Compression of Nanopore FASTQ Files. in Lecture Notes in 
Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture 
Notes in Bioinformatics) 11465 LNBI, 36–47 (Springer, 2019). 
154. Song, S., Guo, Y., Kim, J. S., Wang, X. & Wood, T. K. Phages Mediate Bacterial Self-
Recognition. Cell Rep. 27, 737-749.e4 (2019). 
155. Sagar, S. When two is better than one. Drapers 20 (2008). 
156. Dilthey, A., Meyer, S. & Kaasch, A. J. Increasing the efficiency of long-read sequencing for 
174 
 
hybrid assembly with k-mer-based multiplexing. bioRxiv 680827 (2019). 
157. Krizanovic, K., Sovic, I., Krpelnik, I. & Sikic, M. RNA Transcriptome Mapping with 
GraphMap. bioRxiv 160085 (2017).  
158. Baldwin-Brown, J. G., Weeks, S. C. & Long, A. D. A New Standard for Crustacean 
Genomes: The Highly Contiguous, Annotated Genome Assembly of the Clam Shrimp 
Eulimnadia texana Reveals HOX Gene Order and Identifies the Sex Chromosome. 
Genome Biol. Evol. 10, 143–156 (2017). 
159. Tajiri, M. Comparison of High-Throughput Sequencing for Phage Display Peptide Screening 
on Two Commercially Available Platforms. Int. J. Pept. Res. Ther. 1–7 (2019).  
160. Peng, M., Zhang, Y.-P., Ma, Z. (Sam), Li, L. & Ye, C. Hybrid assembly of ultra-long 
nanopore reads augmented with 10×-genomics contigs: Demonstrated with a human 
genome. Genomics 1–6 (2018).  
161. Mishra, D. C. et al. Strategies and Tools for Sequencing and Assembly of Plant Genomes. 
in The Potato Genome 81–93 (Springer, 2017).  
162. Liu, B., Liu, Y., Zang, T. & Wang, Y. deSALT: fast and accurate long transcriptomic read 
alignment with de Bruijn graph-based index. bioRxiv 612176 (2019).  
163. Greig, D. R., Jenkins, C., Gharbia, S. & Dallman, T. J. Comparison of single nucleotide 
variants identified by Illumina and Oxford Nanopore technologies in the context of a 
potential outbreak of Shiga Toxin Producing Escherichia coli. bioRxiv 570192 (2019).  
164. Maroilley, T. & Tarailo-Graovac, M. Uncovering Missing Heritability in Rare Diseases. 
Genes (Basel). 10, 275 (2019). 
165. Liao, X. et al. Current challenges and solutions of de novo assembly. Quant. Biol. 1–20 
(2019).  
166. Krachunov, M., Nisheva, M. & Vassilev, D. Machine learning models for error detection in 
metagenomics and polyploid sequencing data. Inf. 10, 110 (2019). 
175 
 
167. Banin, A. N. et al. Development of a Versatile, Near Full Genome Amplification and 
Sequencing Approach for a Broad Variety of HIV-1 Group M Variants. Viruses 11, 317 
(2019). 
168. Tapinos, A. et al. The Utility of Data Transformation for Alignment, De Novo Assembly and 
Classification of Short Read Virus Sequences. Viruses 11, 394 (2019). 
169. Murray, K., Dunigan, D. D. & Sayood, K. Dictionary coded profiles and their use with 
nanopore sequencers. in IEEE International Conference on Electro Information Technology 
422–426 (IEEE, 2017).  
170. Krachunov, M., Nisheva, M. & Vassilev, D. Application of Machine Learning Models in Error 
and Variant Detection in High-Variation Genomics Datasets. Computers 6, 29 (2017). 
171. Deveson, I. W. et al. Chiral DNA sequences as commutable controls for clinical genomics. 
Nat. Commun. 10, 1342 (2019). 
172. Coughlan, S. Pathogen genomics of Methicillin resistant Staphylococcus aureus and 
Leishmania. DNA 540, G21E (2017). 
173. Deveson. Chiral DNA sequences as commutable reference standards for clinical genomics. 
bioRxiv August 31, 404285 (2018). 
174. Goldstein, S., Beka, L., Graf, J. & Klassen, J. L. Evaluation of strategies for the assembly of 
diverse bacterial genomes using MinION long-read sequencing. BMC Genomics 20, 23 
(2019). 
175. Johri, S., Doane, M., Allen, L. & Dinsdale, E. Taking Advantage of the Genomics Revolution 
for Monitoring and Conservation of Chondrichthyan Populations. Diversity 11, 49 (2019). 
176. Corresp, J. I. K., Smolander, O. & Pereira, P. A. B. gapFinisher : a reliable gap filling 
pipeline for SSPACE- LongRead scaffolder output. PeerJ Prepr. 5, e3467v1 (2017). 
177. Krych, L. et al. Finally, Bulk Typing of Bacterial Species down to Strain Level using ON-rep-
seq. bioRxiv 34 (2018). 
176 
 
178. Voorhuijzen-Harink, M. M. et al. Toward on-site food authentication using nanopore 
sequencing. Food Chem. X 2, 100035 (2019). 
179. Pancrace, C., Gugger, M. & Calteau, A. Genomics of NRPS/PKS Biosynthetic Gene 
Clusters in Cyanobacteria. Cyanobacteria Omi. Manip. 32, 55–74 (2016). 
180. Sullivan, R., Yau, W. Y., O’Connor, E. & Houlden, H. Spinocerebellar ataxia: an update. J. 
Neurol. 266, 533–544 (2019). 
181. Kiel, M. et al. Identification of novel biomarkers for priority serotypes of Shiga toxin-
producing Escherichia coli and the development of multiplex PCR for their detection. Front. 
Microbiol. 9, 1321 (2018). 
182. Geng, Y. et al. A crowdsourcing method for correcting sequencing errors for the third-
generation sequencing data. in Proceedings - 2017 IEEE International Conference on 
Bioinformatics and Biomedicine, BIBM 2017 2017-January, 1626–1633 (IEEE, 2017). 
183. Rofeh, J. et al. Microfluidic block copolymer membrane arrays for nanopore DNA 
sequencing. Appl. Phys. Lett. 114, 213701 (2019). 
184. Anderson, M. W. Emerging Next-Generation Sequencing Technologies. in Genomic 
Applications in Pathology 29–39 (Springer, 2019). 
185. Gatzmann, F. et al. The methylome of the marbled crayfish links gene body methylation to 
stable expression of poorly accessible genes. Epigenetics Chromatin 11, 57 (2018). 
186. Schonrock, N. et al. The RNA modification landscape in human disease. Rna 23, 1754–
1769 (2017). 
187. Lu, H., Giordano, F. & Ning, Z. Oxford Nanopore MinION Sequencing and Genome 







In 2006 the release of the first examples of next generation sequencing technologies 
heralded a wave of novel discovery in the field of biological and medical sciences. In the 
early stages of the development of these systems it was clear that the technology had huge 
potential. Although these early iterations had a great deal of promise, there were limitations. 
Whilst the Illumina short read sequencing technology could produce a large volume of data 
in comparison to existing technology, systematic constraints meant that the data generated 
had to be treated in a very different way and new bioinformatic techniques had to be 
developed. The read lengths generated by the early Illumina machines were short (~32 bp) 
and the error rate was high. Pyrosequencing could produce longer reads (~100 bp or even 
longer) but could only produce a fraction of the volume of data. However, these new 
technologies, experimental protocols and data analysis pipelines quickly matured and 
particularly Illumina went on to dominate the sequencing landscape for the next decade. 
The move towards third generation sequencing technologies was the next major 
development, these new technologies released in the early 2010’s aimed to address the 
major limitations of the NGS by producing ultra-long reads. These ultra-long sequence 
reads would resolve questions which previous technologies had been unable to address 
such as the accurate scaffolding of genome assemblies generated using short read 
sequencing and the resolution of long repeat regions of genomic sequence or haplotypes. 
There are/were two main competitors, Pacific Biosciences Single Molecule Real Time 
(SMRT) sequencing and Oxford Nanopore Technologies (ONT) nanopore sequencing. 
ONT comercially released their first sequencer, the MinION in May 2015 but 
released it to selected research groups prior to this in an early access evaluation program 
(MinION Early Access Program) in 2014. The MinION was the first commercial sequencer 
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to utilise nanopore sequencing: the determination of the sequence of discreet molecules 
of DNA from the changes in electrical field as the bases pass through protein nanopores 
in an electrically resistant polymer membrane. The MinION does not measure each base 
individually, instead it records the changes per 5 bases (5mers) (or more recently 6mers) 
that pass through the pore. This process complicates the post sequencing analysis 
somewhat. As the molecule of DNA or RNA moves through the nanopore one base at a 
time, the micro changes in current across 5mer is recorded. These then require 
complicated algorithms to determine the single base sequence. Sequencing single 
molecules of template DNA eradicated the need for a PCR amplification step in the 
sequencing process therefore avoiding the biases of this process. 
Prior to this study limited data had been published concerning the volume, quality 
and limitations of the data produced by the ONT MinION Mikheyev and Tin succeeded in 
sequencing the Lambda Phage genome although this study suggested that less than 1% of 
data generated by their sequencing run was alignable to the reference 1. Loman et al and 
Ashton et al were more optimistic, claiming to sequence the entire E. coli genome and 
resolve some interesting genomic features of the Salmonella typhi genome respectively 2,3. 
Although there was limited data from projects utilising this exciting novel sequencing 
technology, the potential seemed huge, particularly for the field of bacterial genomics. The 
possibility of ultra-long, single molecule reads of DNA sequence had the potential to answer 
many important questions which researchers had been unable to answer due to the short 
read limitations of previous technologies. Certain facets of bacterial DNA sequence 
including long repetitive regions and multiple sequence repeats within the genomes or 
plasmids of bacterial strains meant the analysis of short read data was unable to generate 
contiguous assemblies of these strains. The ONT MinION offered these long contiguous 
reads which could be used to sequence these regions and close assemblies. Not only this 
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but the portable nature and low logistical overhead of the MinION meant that there was the 
potential to utilise the MinION in the field to track bacterial disease outbreaks and as an in 
situ environmental sensor.  
The aim of the study covered in this chapter was to assess the potential of the ONT 
MinION as a tool for use in the field of bacterial sequencing. The work covered thus far in 
this thesis utilised NGS technologies to investigate bacterial genomics. However, the 
advent of third generation sequencing presented new opportunities to further advance the 
field. The ONT MinION in particular posses`sed exciting characteristics which could 
potentially be utilised to conduct studies such as those in this thesis quickly in the field 
characterising novel bacterial outbreaks and tracking their spread. The aim was to fully 
evaluate the volume and error rate of the sequence data generated and characterise any 
systematic biases which may need to be taken into consideration. During the MAP the 
sequencing chemistry was evolving at a fast pace, we focussed on the R6 version (the 
latest version available at the time). We aimed to assess the utility of Minion data for 
bacterial genomics and meta-genomics. To this end we sequenced a mix of three species 
with a variety of G + C contents: Borrelia burgdorferi (28.6%), Streptomyces avermitilis 
(70.7%) and E. coli (50.8%). 
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and pipeline code to assess, analyse and optimise the performance of this exciting novel 
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novel data types produced and where required the production of bespoke scripts to handle the 
unique analysis opportunities presented by this project. 
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Species Raw read pairs Trimmed read pairs Genome coverage 
S. avermitilis 1232293 1201308 59 
E. coli 643253 634237 39 




Alignment software Reads 
aligned  
% total reads 
aligned 
Bases aligned % total bases 
aligned 
Bowtie2 --very-sensitive-local 1303  2.77 1833495  1.95 
BWA mem default 2111  4.48 129618 0.138 
BWA mem ont2d 15115  32.1 34336255 36.5 
 
 
Supplementary Table 1 MiSeq sequencing statistics 
Supplementary Table 2 Alignment rates of alternative software  
The alignment rates for alternative alignment software. Bowtie2 was run with --very-sensitive-local setting (the best 
performing of the pre-sets) while BWA mem was run with default settings and ont2d (the pre-set developed for ONT 
reads). 
 
Supplementary Figure 1 Bioanalyser trace compared to read mass 
The DNA fragment size distribution of the libraries before mixing was checked on a Bioanalyser 
7500 DNA chip (Agilent Technologies). The spike starting at 10000 bases is the ladder. The 










Figure 3 GC 
content of the 
sections of the 
reference genome 
reads align to 
verus their error 
rate 
The G+C content of 
the sections of the 
reference genome 
to which reads align 
does not correlate 
with error rate 
(correlation 
coefficient of 0.014). 
 
 
Supplementary Figure 2 
G+C content of aligned 
portions of reads verus 
their error rate 
The G+C content of the 
aligned portion of a read 
does not correlate with its 
error rate (correlation 


















The B. burgdorferi 
genome was split 
into windows of 
1000 bp across 
which the 
coverage depth 
was compared to 
the G+C content (r 









The E. coli 
genome was split 
into windows of 
1000 bp across 
which the 
coverage depth 
was compared to 
the G+C content 

























Figure 6 G+C 
content versus 
coverage depth for 
Quick et al. 
Template reads 
The E. coli genome 
was split into 
windows of 1000 bp 
across which the 
coverage depth for 
the Quick et al. 
Template reads was 
compared to the 






Figure 7 G+C 
content versus 
coverage depth 
for Quick et al. 
High Quality Two 
Direction reads 
The E. coli genome 
was split into 
windows of 1000 
bp across which 
the coverage depth 
for the Quick et al. 
High Quality Two 
Direction reads 
was compared to 
the G+C content (r 




































Supplementary Figure 8 
MinION quality scores do 
not follow Phred 
The likelihood of error for a 
base with a specific quality 
score does not match the 
error rate expected for a 









This thesis represents a significant contribution to the field of genomics 
of bacterial pathogens, a field with potential to have a huge impact on human 
health and global food security. The aim was to explore the use of NGS as a 
tool for understanding and combatting bacterial pathogens of both humans and 
plants.  
One of the most important groups of plant pathogens is the genus 
Xanthomonas, which is responsible for devastating infections such as bacterial 
leaf blight, common bacterial blight and black rot of crucifers. Xanthomonas 
species are a significant problem to global agriculture being responsible large 
scale crop losses worldwide. Underlining this is the presence of three 
Xanthomonas species in the top 10 bacterial pathogens of plants 1.  
In the first two chapters of the thesis we used NGS to investigate the 
genomics of host adaptation and phenotypic convergence within the 
xanthomonads. We investigated the evolutionary history of Xanthomonas 
pathogens of bean and sugar cane uncovered evidence of recent horizontal 
gene transfer events associated with convergent evolution among 
phylogenetically distant strains sharing a common host. 
 The motivation for sequencing Xanthomonas axonopodis pv. 
vasculorum (Xav) was to elucidate its relationship with X. vasicola pv. 
vasculorum. Both these taxa were previously grouped together as a single 
taxon, namely X. campestris pv. vasculorum. Recent work (reviewed in 
Studholme et al. in press) demonstrated that they belong to two distinct species 
and have independently converged on life as a sugarcane pathogen. Xav 
NCPPB 900, isolated from sugarcane on Réunion island was sequenced, 
assembled, annotated and analysed. Multi-locus sequence analysis confirmed 
that Xav NCPPB900 fell within the X. axonopodis clade of X. campestris pv. 
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vasculorum. A genomic region was identified closely resembling that found in X. 
vasicola strains also known to infect sugar cane. This suggests that these 
genomic features have been transferred between Xanthomonas species. A 
T3SS gene cluster with a range of predicted effectors was also identified 
including TAL effectors which may contribute to the ability of Xav to colonise 
this host. It would be interesting to compare the T3SS effector profile of 
Xanthomonas sugar cane pathogens to assess to what extent these potential 
virulence factors have contributed to the phenotypic convergence of these 
phylogenetically distant pathogens. Our NCPPB 900 genome sequence has 
been cited by two subsequent papers, characterising and classifying novel 
strains of Xanthomonas 2,3.  
  To further investigate the genomics of host adaptation and phenotypic 
conversion we focused on two species of Xanthomonas bean pathogens: X. 
axononpodis pv. Phaseoli and X. fuscans subsp. fuscans. We sequenced and 
analysed 26 strains known to cause common bacterial blight on three important 
species of bean: common bean (Phaseolus vulgaris), Lima bean (Phaseolus 
lunatus) and lablab bean (Lablab purpureus). The genomic analysis of these 
strains uncovered a high degree of genetic variation within both taxa, including 
single nucleotide changes and variable gene content. The results of our 
analysis also suggested a recent acquisition of over 100 genes by X. 
axonopodis pv. phaseoli from X. fuscans subsp. fuscans which may have a role 
in the phenotypic convergence of these strains. Interestingly, the four strains 
isolated from Lablab bean were shown to represent a previously undescribed 
phylogenetically distinct genetic lineage closely related to X. axonopodis pv. 
glycines. These novel findings contribute to the knowledge of the causes of this 
devastating bacterial disease and provide markers which could prove useful in 
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identifying outbreaks and contributing to the surveillance and tracking of the 
pathogen spread, helping to manage the disease.  
The work presented in this chapter has been cited a number of papers since its 
publication, including several exploring the genomics of host specificity and 
adaptation 4,5,6 in xanthomonads and others investigating genomic and 
phenotypic diversity within the xanthomonads7,8.  
The second two chapters of the thesis introduce a related but distinct 
concept: the use of NGS to investigate and inform the surveillance and tracking 
of newly emerging plant and human pathogens. In chapter 4 we used NGS to 
discover an association between a newly identified strain of the human 
pathogen C. jejuni showing severe symptoms and acquisition of genes 
encoding a T6SS. The T6SS was recently discovered in bacteria and was 
predicted to be an important virulence factor similar to other secretion systems 
and their effectors and although it had been previously identified in the 
important food-borne pathogen C. jejuni. It was unknown if the T6SS was a 
common feature in C. jejuni strains and whether it was associated with more 
virulent forms of infection. This study surveyed all sequenced strains of C. jejuni 
for T6SS gene clusters. Evidence of a T6SS was indeed identified in a group of 
these strains. The Hcp gene was identified as a potential molecular marker for 
an intact T6SS and using this marker, it was shown that presence of the T6SS 
was significantly associated with the a more serious form of campylobacteriosis. 
Further to this it was found that the T6SS was significantly more prevalent in 
Asian isolates than in isolates from the UK. These findings will inform the 
surveillance of possible infectious C. jejuni strains during future import of 
chicken from the Far East.  
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Since its publication, the work from this chapter has had a significant 
impact - it has been cited by 22 papers Including several identifying further 
T6SS positive C. jejuni strains 9–12 and several further investigating the 
influence of the T6SS on virulence in C. jejuni 13–16. Latterly, advances have 
even been made in the reduction of virulence of T6SS carrying C. jejuni 17,18 
and most recently the Hcp gene has been used as a marker to survey the 
presence of the T6SS in Helicobacter pullorum 19 from chicken and suggesting 
that similar to the study presented here that the T6SS is indicative of a more 
virulent form of infection.  
A further example of the value of rapid and cheap genome sequencing is 
in the characterisation of emerging pathogens. This is exemplified by previous 
studies such as the crowd-sourced analysis of an Escherichia coli outbreak in 
Germany in 2011 20 and by our study on the mysterious Nyagatare strain that 
recently appeared in Rwanda, causing unusual symptoms on common bean. 
Genomic sequencing identified this strain as being quite unrelated to previously 
known bean pathogens and ultimately as a member of the species X. cannabis, 
which includes a range of pathogens, weakly pathogenic strains and non-
pathogens. Unlike some members of the species, it appears to encode a 
potentially functional T3SS and virulence effectors. Further investigation of the 
effector complement of this pathogen could reveal insight into the adaptation of 
this pathogen to its host. Several unusual genomic features were identified 
including a 100 kb sequence with little or no similarity to other xanthomonads 
and a unique LPS synthesis gene cluster. These features could potentially be 
used molecular markers to track the spread of this pathogen and inform 
molecular diagnostics and detection. This study will aid epidemiological 
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investigations of Xanthomonas outbreaks which have the potential to seriously 
impact bean crop production which is vital in many parts of the globe.  
The work shown here provides important insight into the organisms 
concerned where Identification of horizontally acquired virulence-associated 
genes has applications in basic research. But, this work also demonstrates the 
utility of NGS to contribute to the investigation, detection and surveillance of 
emerging plant and human pathogens 
Work from this chapter has been cited by several publications; 
contributing to both a review of the ecology, physiology and host specificity of 
Xanthomonas 5 and a paper concerning the evolution of pathogenicity in the 
Xanthomonas species 21. The work in this chapter has also contributed to 
another publication concerning the characterisation of newly identified 
Xanthomonas pathogens of watercress 22. Finally, this work has been built upon 
by a paper introducing two further strains which are shown to be in the same 
species level clade as the xanthomonad presented in this chapter. These newly 
sequenced strains are pathogenic on the cannabis plant and have no evidence 
of T3SS effectors, but MLSA analysis confirms they are closely phylogenetically 
related 23.  
Finally, the bulk of the work presented in this thesis is based on data 
generated from NGS technologies. Whilst NGS offers a wealth of possibilities 
which are still being explored, chapter 6 of this thesis presents an assessment 
of the performance of the third generation sequencing platform the ONT 
MinION. This new technology offered portable, financially viable real time 
sequencing based on nanopore technology with advertised read lengths into 
the 100’s of kilobases. The results presented are based on the pre-release 
access program and offer a comprehensive evaluation of the performance of 
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the technology at an early stage of release. In order to assess the MinIONs 
performance a mixture of three bacteria with varying genome sizes and G + C 
content were sequenced. It was shown even at this early stage of development 
of both the MinION and the sequencing chemistry that read lengths of up to 100 
kb could be generated. However, the error rate was shown to be ~38% but, 
even with the relatively high error rate it was still possible to align these reads to 
a reference genome and that there were single reads covering the entire rRNA 
operon which would have been unheard of prior to third generation sequencing. 
There did however appear to be limitations particularly in high G + C content 
sequences. Despite these limitations, the MinION presents a fantastic resource 
for bacterial genomics going forward. With the long reads generated from single 
molecule sequencing offering the possibility to unambiguously determine the 
sequence of repetitive regions such as TAL effectors and repeat regions which 
are known to be common in bacterial genomes. Further the portable nature of 
this technology makes it ideal for use in the field, investigating bacterial disease 
outbreaks and providing immediate data to use molecular analysis to inform 
epidemiology and track spread. Interest in this exciting new technology and the 
important nature of this work was subsequently demonstrated by the ~200 
citations generated.  
In conclusion, the highly cited work presented in this thesis has 
contributed important findings to the field of bacterial genomics. It reveals novel 
insights into the evolution of pathogenicity and potential molecular markers for 
taxonomic classification and epidemiological tracking of both human and plant 
pathogens. The methods presented here have been used subsequently several 
times to quickly characterise emerging bacterial disease outbreaks, track their 
spread and assess the threat posed. Examples of this can be found in both 
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human and plant pathogens. This work has enormous potential to inform both 
human health and global food security. It also introduces and evaluates a novel 





1. Mansfield, J. et al. Top 10 plant pathogenic bacteria in molecular plant 
pathology. Mol. Plant Pathol. 13, 614–629 (2012). 
2. Studholme, D. J. et al. Transfer of Xanthomonas campestris pv. arecae, 
and Xanthomonas campestris pv. musacearum to Xanthomonas vasicola 
(Vauterin) as Xanthomonas vasicola pv. arecae comb. nov., and 
Xanthomonas vasicola pv. musacearum comb. nov. and description of 
Xanthomonas va. bioRxiv 571166 (2019).  
3. Lang, J. M. et al. Detection and Characterization of Xanthomonas 
vasicola pv. vasculorum (Cobb 1894) comb. nov. Causing Bacterial Leaf 
Streak of Corn in the United States. Phytopathology 107, 1312–1321 
(2017). 
4. Ruh, M., Briand, M., Bonneau, S., Jacques, M. A. & Chen, N. W. G. 
Xanthomonas adaptation to common bean is associated with horizontal 
transfers of genes encoding TAL effectors. BMC Genomics 18, 1–18 
(2017). 
5. Jacques, M.-A. et al. Using Ecology, Physiology, and Genomics to 
Understand Host Specificity in Xanthomonas. Annu. Rev. Phytopathol. 
54, 163–187 (2016). 
6. Rai, K. K., Rai, N. & Rai, S. P. Recent advancement in modern genomic 
tools for adaptation of Lablab purpureus L to biotic and abiotic stresses: 
present mechanisms and future adaptations. Acta Physiol. Plant. 40, 1–
29 (2018). 
7. Midha, S. et al. Population genomic insights into variation and evolution of 
Xanthomonas oryzae pv. oryzae. Sci. Rep. 7, 1–13 (2017). 
8. Tugume, J. K., Tusiime, G., Sekamate, A. M., Buruchara, R. & 
205 
 
Mukankusi, C. M. Diversity and interaction of common bacterial blight 
disease-causing bacteria (Xanthomonas spp.) with Phaseolus vulgaris L. 
Crop J. 7, 1–7 (2019). 
9. Ungureanu, V. A. et al. Virulence of a T6SS Campylobacter jejuni chicken 
isolate from North Romania. BMC Res. Notes 12, 1–7 (2019). 
10. Siddiqui, F. et al. Molecular detection identified a type six secretion 
system in Campylobacter jejuni from various sources but not from human 
cases. J. Appl. Microbiol. 118, 1191–1198 (2015). 
11. Clark, C. G. et al. Comparison of genomes and proteomes of four whole 
genome-sequenced Campylobacter jejuni from different phylogenetic 
backgrounds. PLoS One 13, 1–28 (2018). 
12. Ugarte-Ruiz, M. et al. Prevalence of Type VI Secretion System in Spanish 
Campylobacter jejuni Isolates. Zoonoses Public Health 62, 497–500 
(2015). 
13. Singh, A., Nisaa, K., Bhattacharyya, S. & Mallick, A. I. Immunogenicity 
and protective efficacy of mucosal delivery of recombinant hcp+ of 
Campylobacter jejuni Type VI secretion system (T6SS)in chickens. Mol. 
Immunol. 111, 182–197 (2019). 
14. Agnetti, J. et al. Clinical impact of the type VI secretion system on 
virulence of Campylobacter species during infection. BMC Infect. Dis. 19, 
237 (2019). 
15. Corcionivoschi, N. et al. Virulence characteristics of hcp+ Campylobacter 
jejuni and Campylobacter coli isolates from retail chicken. Gut Pathog. 7, 
1–11 (2015). 
16. Iglesias-Torrens, Y. et al. Population structure, antimicrobial resistance, 
and virulence-associated genes in Campylobacter jejuni isolated from 
206 
 
three ecological niches: Gastroenteritis patients, broilers, and wild birds. 
Front. Microbiol. 9, 1–13 (2018). 
17. Sima, F. et al. A novel natural antimicrobial can reduce the in vitro and in 
vivo pathogenicity of T6SS positive Campylobacter jejuni and 
campylobacter coli chicken isolates. Front. Microbiol. 9, 1–11 (2018). 
18. Bokhari, H. Exploitation of microbial forensics and nanotechnology for the 
monitoring of emerging pathogens. Crit. Rev. Microbiol. 44, 504–521 
(2018). 
19. Javed, K. et al. Prevalence and role of Type six secretion system in 
pathogenesis of emerging zoonotic pathogen Helicobacter pullorum from 
retail poultry. Avian Pathol. 1–26 (2019).  
20. Rohde, H. et al. Open-Source Genomic Analysis of Shiga-Toxin–
Producing E. coli O104:H4. N. Engl. J. Med. 365, 718–724 (2011). 
21. Meline, V. et al. Role of the acquisition of a type 3 secretion system in the 
emergence of novel pathogenic strains of Xanthomonas. Mol. Plant 
Pathol. 20, 33–50 (2019). 
22. Vicente, J. G., Rothwell, S., Holub, E. B. & Studholme, D. J. Pathogenic, 
phenotypic and molecular characterisation of xanthomonas nasturtii sp. 
Nov. And xanthomonas floridensis sp. Nov., new species of xanthomonas 
associated with watercress production in Florida. Int. J. Syst. Evol. 
Microbiol. 67, 3645–3654 (2017). 
23. Jacobs, J. M., Pesce, C., Lefeuvre, P. & Koebnik, R. Comparative 
genomics of a cannabis pathogen reveals insight into the evolution of 






This appendix contains a list of published papers based on work carried out by the 




1. Wagley, S. et al. Galleria mellonella as an infection model to investigate 
virulence of Vibrio parahaemolyticus. Virulence 9, 197–207 (2017). 
2. McDonagh, L. M., West, H., Harrison, J. W. & Stevens, J. R. Which 
mitochondrial gene (if any) is best for insect phylogenetics? Insect Syst. Evol. 
47, 245–266 (2016). 
3. Harrison, J., Grant, M. R. & Studholme, D. J.  Draft Genome Sequences of 
Two Strains of Xanthomonas arboricola pv. celebensis Isolated from Banana 
Plants . Genome Announc. 4, e01705-15 (2016). 
4. Harrison, J. & Studholme, D. J. Recently published Streptomyces genome 
sequences. Microb. Biotechnol. 7, 373–380 (2014). 
5. Harrison, J., Dornbusch, M. R., Samac, D. & Studholme, D. J.  Draft Genome 
Sequence of Pseudomonas syringae pv. syringae ALF3 Isolated from Alfalfa . 
Genome Announc. 4, 2015–2016 (2016). 
6. Harrison, J. et al. A Draft Genome Sequence for Ensete ventricosum, the 
Drought-Tolerant “Tree Against Hunger”. Agronomy 4, 13–33 (2014). 
7. Quinn, L. et al. Genome-wide sequencing of Phytophthora lateralis reveals 
genetic variation among isolates from Lawson cypress (Chamaecyparis 
lawsoniana) in Northern Ireland. FEMS Microbiol. Lett. 344, 179–185 (2013). 
 
 
